UMAP plots with 2-group classification for ATC:skmeans and 2-group classification for SD:kmeans:
Signature genes from two classifications:
Overlap of the two signature lists:
The signature genes are put into three groups, termed as:
Gene Ontology enrichment to the three set of genes are performed by hypergenometric test (with the clusterProfiler package). BP ontologies (Biological Process) is only applied and the significant GO terms are filtered by FDR < 0.01. The enriched GO terms are visualized as a heatmap by their similarities between GO terms (with GOSemSim package). GO terms are split and clustered with the simplifyEnrichment package. The keywords of the summaries of GO functions in each cluster are visualized by word clouds.
The most left heatmap illustrates the FDR of GO terms for each gene list. Red basically means significant.
ID | Description | GeneRatio | BgRatio | pvalue | p.adjust | Count |
---|---|---|---|---|---|---|
GO:0033993 | response to lipid | 81/553 | 865/18862 | 0e+00 | 0e+00 | 81 |
GO:0014070 | response to organic cyclic compound | 73/553 | 907/18862 | 0e+00 | 0e+00 | 73 |
GO:0009725 | response to hormone | 71/553 | 876/18862 | 0e+00 | 0e+00 | 71 |
GO:0043270 | positive regulation of ion transport | 59/553 | 660/18862 | 0e+00 | 0e+00 | 59 |
GO:0003013 | circulatory system process | 56/553 | 610/18862 | 0e+00 | 0e+00 | 56 |
GO:0051050 | positive regulation of transport | 69/553 | 883/18862 | 0e+00 | 0e+00 | 69 |
GO:0009611 | response to wounding | 57/553 | 654/18862 | 0e+00 | 0e+00 | 57 |
GO:0007417 | central nervous system development | 72/553 | 980/18862 | 0e+00 | 0e+00 | 72 |
GO:0019725 | cellular homeostasis | 69/553 | 937/18862 | 0e+00 | 0e+00 | 69 |
GO:0006935 | chemotaxis | 54/553 | 643/18862 | 0e+00 | 0e+00 | 54 |
GO:0042330 | taxis | 54/553 | 645/18862 | 0e+00 | 0e+00 | 54 |
GO:0008284 | positive regulation of cell population proliferation | 68/553 | 941/18862 | 0e+00 | 0e+00 | 68 |
GO:0042391 | regulation of membrane potential | 42/553 | 431/18862 | 0e+00 | 0e+00 | 42 |
GO:0007268 | chemical synaptic transmission | 55/553 | 683/18862 | 0e+00 | 0e+00 | 55 |
GO:0098916 | anterograde trans-synaptic signaling | 55/553 | 683/18862 | 0e+00 | 0e+00 | 55 |
GO:0044070 | regulation of anion transport | 63/553 | 850/18862 | 0e+00 | 0e+00 | 63 |
GO:0008015 | blood circulation | 47/553 | 527/18862 | 0e+00 | 0e+00 | 47 |
GO:0010562 | positive regulation of phosphorus metabolic process | 69/553 | 982/18862 | 0e+00 | 0e+00 | 69 |
GO:0045937 | positive regulation of phosphate metabolic process | 69/553 | 982/18862 | 0e+00 | 0e+00 | 69 |
GO:0035239 | tube morphogenesis | 65/553 | 900/18862 | 0e+00 | 0e+00 | 65 |
GO:0099537 | trans-synaptic signaling | 55/553 | 690/18862 | 0e+00 | 0e+00 | 55 |
GO:0099536 | synaptic signaling | 56/553 | 712/18862 | 0e+00 | 0e+00 | 56 |
GO:0043066 | negative regulation of apoptotic process | 64/553 | 881/18862 | 0e+00 | 0e+00 | 64 |
GO:0006936 | muscle contraction | 37/553 | 352/18862 | 0e+00 | 0e+00 | 37 |
GO:0030855 | epithelial cell differentiation | 59/553 | 775/18862 | 0e+00 | 0e+00 | 59 |
GO:0051046 | regulation of secretion | 51/553 | 613/18862 | 0e+00 | 0e+00 | 51 |
GO:0042493 | response to drug | 37/553 | 359/18862 | 0e+00 | 0e+00 | 37 |
GO:0048732 | gland development | 40/553 | 413/18862 | 0e+00 | 0e+00 | 40 |
GO:0061564 | axon development | 45/553 | 507/18862 | 0e+00 | 0e+00 | 45 |
GO:0055082 | cellular chemical homeostasis | 60/553 | 811/18862 | 0e+00 | 0e+00 | 60 |
GO:0003012 | muscle system process | 42/553 | 453/18862 | 0e+00 | 0e+00 | 42 |
GO:0043069 | negative regulation of programmed cell death | 64/553 | 902/18862 | 0e+00 | 0e+00 | 64 |
GO:0008285 | negative regulation of cell population proliferation | 57/553 | 752/18862 | 0e+00 | 0e+00 | 57 |
GO:0002790 | peptide secretion | 39/553 | 401/18862 | 0e+00 | 0e+00 | 39 |
GO:0044057 | regulation of system process | 49/553 | 591/18862 | 0e+00 | 0e+00 | 49 |
GO:0023061 | signal release | 43/553 | 475/18862 | 0e+00 | 0e+00 | 43 |
GO:0060078 | regulation of postsynaptic membrane potential | 22/553 | 136/18862 | 0e+00 | 0e+00 | 22 |
GO:0007409 | axonogenesis | 42/553 | 460/18862 | 0e+00 | 0e+00 | 42 |
GO:0071417 | cellular response to organonitrogen compound | 51/553 | 643/18862 | 0e+00 | 0e+00 | 51 |
GO:0060322 | head development | 56/553 | 750/18862 | 0e+00 | 0e+00 | 56 |
GO:0010817 | regulation of hormone levels | 44/553 | 510/18862 | 0e+00 | 0e+00 | 44 |
GO:0048514 | blood vessel morphogenesis | 52/553 | 677/18862 | 0e+00 | 0e+00 | 52 |
GO:1901699 | cellular response to nitrogen compound | 53/553 | 698/18862 | 0e+00 | 0e+00 | 53 |
GO:1903793 | positive regulation of anion transport | 42/553 | 478/18862 | 0e+00 | 0e+00 | 42 |
GO:0001944 | vasculature development | 57/553 | 786/18862 | 0e+00 | 0e+00 | 57 |
GO:0072507 | divalent inorganic cation homeostasis | 43/553 | 499/18862 | 0e+00 | 0e+00 | 43 |
GO:0072503 | cellular divalent inorganic cation homeostasis | 42/553 | 480/18862 | 0e+00 | 0e+00 | 42 |
GO:0045785 | positive regulation of cell adhesion | 39/553 | 425/18862 | 0e+00 | 0e+00 | 39 |
GO:0046879 | hormone secretion | 32/553 | 302/18862 | 0e+00 | 0e+00 | 32 |
GO:0060548 | negative regulation of cell death | 66/553 | 992/18862 | 0e+00 | 0e+00 | 66 |
GO:0071692 | protein localization to extracellular region | 36/553 | 375/18862 | 0e+00 | 0e+00 | 36 |
GO:0001568 | blood vessel development | 55/553 | 754/18862 | 0e+00 | 0e+00 | 55 |
GO:0042327 | positive regulation of phosphorylation | 62/553 | 908/18862 | 0e+00 | 0e+00 | 62 |
GO:0001525 | angiogenesis | 47/553 | 588/18862 | 0e+00 | 0e+00 | 47 |
GO:0006875 | cellular metal ion homeostasis | 46/553 | 575/18862 | 0e+00 | 0e+00 | 46 |
GO:0007411 | axon guidance | 30/553 | 277/18862 | 0e+00 | 0e+00 | 30 |
GO:0048511 | rhythmic process | 31/553 | 294/18862 | 0e+00 | 0e+00 | 31 |
GO:0009914 | hormone transport | 32/553 | 312/18862 | 0e+00 | 0e+00 | 32 |
GO:0003018 | vascular process in circulatory system | 28/553 | 245/18862 | 0e+00 | 0e+00 | 28 |
GO:0097485 | neuron projection guidance | 30/553 | 278/18862 | 0e+00 | 0e+00 | 30 |
GO:0048545 | response to steroid hormone | 33/553 | 330/18862 | 0e+00 | 0e+00 | 33 |
GO:0007188 | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 27/553 | 230/18862 | 0e+00 | 0e+00 | 27 |
GO:0030072 | peptide hormone secretion | 28/553 | 247/18862 | 0e+00 | 0e+00 | 28 |
GO:1903530 | regulation of secretion by cell | 45/553 | 561/18862 | 0e+00 | 0e+00 | 45 |
GO:1901652 | response to peptide | 43/553 | 521/18862 | 0e+00 | 0e+00 | 43 |
GO:0030155 | regulation of cell adhesion | 53/553 | 732/18862 | 0e+00 | 0e+00 | 53 |
GO:0001934 | positive regulation of protein phosphorylation | 57/553 | 824/18862 | 0e+00 | 0e+00 | 57 |
GO:0043068 | positive regulation of programmed cell death | 46/553 | 590/18862 | 0e+00 | 0e+00 | 46 |
GO:0055074 | calcium ion homeostasis | 39/553 | 454/18862 | 0e+00 | 0e+00 | 39 |
GO:0043065 | positive regulation of apoptotic process | 45/553 | 574/18862 | 0e+00 | 0e+00 | 45 |
GO:0120039 | plasma membrane bounded cell projection morphogenesis | 49/553 | 659/18862 | 0e+00 | 0e+00 | 49 |
GO:0071396 | cellular response to lipid | 44/553 | 556/18862 | 0e+00 | 0e+00 | 44 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 45/553 | 579/18862 | 0e+00 | 0e+00 | 45 |
GO:0048858 | cell projection morphogenesis | 49/553 | 663/18862 | 0e+00 | 0e+00 | 49 |
GO:0022409 | positive regulation of cell-cell adhesion | 29/553 | 276/18862 | 0e+00 | 0e+00 | 29 |
GO:0046883 | regulation of hormone secretion | 28/553 | 260/18862 | 0e+00 | 0e+00 | 28 |
GO:0040007 | growth | 60/553 | 908/18862 | 0e+00 | 0e+00 | 60 |
GO:0006874 | cellular calcium ion homeostasis | 38/553 | 442/18862 | 0e+00 | 0e+00 | 38 |
GO:0007420 | brain development | 51/553 | 709/18862 | 0e+00 | 0e+00 | 51 |
GO:0048812 | neuron projection morphogenesis | 48/553 | 645/18862 | 0e+00 | 0e+00 | 48 |
GO:0006954 | inflammatory response | 54/553 | 775/18862 | 0e+00 | 0e+00 | 54 |
GO:0009306 | protein secretion | 34/553 | 367/18862 | 0e+00 | 0e+00 | 34 |
GO:0035592 | establishment of protein localization to extracellular region | 34/553 | 368/18862 | 0e+00 | 0e+00 | 34 |
GO:0055065 | metal ion homeostasis | 48/553 | 647/18862 | 0e+00 | 0e+00 | 48 |
GO:0045597 | positive regulation of cell differentiation | 57/553 | 845/18862 | 0e+00 | 0e+00 | 57 |
GO:0043410 | positive regulation of MAPK cascade | 42/553 | 525/18862 | 0e+00 | 0e+00 | 42 |
GO:0050673 | epithelial cell proliferation | 37/553 | 428/18862 | 0e+00 | 0e+00 | 37 |
GO:0010942 | positive regulation of cell death | 48/553 | 652/18862 | 0e+00 | 0e+00 | 48 |
GO:0030003 | cellular cation homeostasis | 48/553 | 655/18862 | 0e+00 | 0e+00 | 48 |
GO:0050678 | regulation of epithelial cell proliferation | 34/553 | 374/18862 | 0e+00 | 0e+00 | 34 |
GO:0032990 | cell part morphogenesis | 49/553 | 679/18862 | 0e+00 | 0e+00 | 49 |
GO:0000904 | cell morphogenesis involved in differentiation | 51/553 | 723/18862 | 0e+00 | 0e+00 | 51 |
GO:0098609 | cell-cell adhesion | 58/553 | 880/18862 | 0e+00 | 0e+00 | 58 |
GO:0022407 | regulation of cell-cell adhesion | 37/553 | 437/18862 | 0e+00 | 0e+00 | 37 |
GO:0090087 | regulation of peptide transport | 44/553 | 580/18862 | 0e+00 | 0e+00 | 44 |
GO:0002791 | regulation of peptide secretion | 30/553 | 308/18862 | 0e+00 | 0e+00 | 30 |
GO:0007610 | behavior | 42/553 | 541/18862 | 0e+00 | 0e+00 | 42 |
GO:0099565 | chemical synaptic transmission, postsynaptic | 17/553 | 105/18862 | 0e+00 | 0e+00 | 17 |
GO:0006873 | cellular ion homeostasis | 48/553 | 668/18862 | 0e+00 | 0e+00 | 48 |
GO:0006937 | regulation of muscle contraction | 21/553 | 161/18862 | 0e+00 | 0e+00 | 21 |
GO:0050878 | regulation of body fluid levels | 40/553 | 503/18862 | 0e+00 | 0e+00 | 40 |
GO:0090276 | regulation of peptide hormone secretion | 24/553 | 209/18862 | 0e+00 | 0e+00 | 24 |
GO:0048598 | embryonic morphogenesis | 43/553 | 569/18862 | 0e+00 | 0e+00 | 43 |
GO:0031667 | response to nutrient levels | 37/553 | 451/18862 | 0e+00 | 0e+00 | 37 |
GO:0090066 | regulation of anatomical structure size | 39/553 | 493/18862 | 0e+00 | 0e+00 | 39 |
GO:0055080 | cation homeostasis | 50/553 | 730/18862 | 0e+00 | 0e+00 | 50 |
GO:0097190 | apoptotic signaling pathway | 43/553 | 580/18862 | 0e+00 | 0e+00 | 43 |
GO:0045471 | response to ethanol | 18/553 | 126/18862 | 0e+00 | 0e+00 | 18 |
GO:0070268 | cornification | 17/553 | 113/18862 | 0e+00 | 0e+00 | 17 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 50/553 | 737/18862 | 0e+00 | 0e+00 | 50 |
GO:0060079 | excitatory postsynaptic potential | 16/553 | 100/18862 | 0e+00 | 0e+00 | 16 |
GO:1903522 | regulation of blood circulation | 28/553 | 290/18862 | 0e+00 | 0e+00 | 28 |
GO:0098771 | inorganic ion homeostasis | 50/553 | 740/18862 | 0e+00 | 0e+00 | 50 |
GO:0007189 | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 19/553 | 143/18862 | 0e+00 | 0e+00 | 19 |
GO:0070482 | response to oxygen levels | 33/553 | 385/18862 | 0e+00 | 0e+00 | 33 |
GO:0007159 | leukocyte cell-cell adhesion | 32/553 | 366/18862 | 0e+00 | 0e+00 | 32 |
GO:0050804 | modulation of chemical synaptic transmission | 34/553 | 405/18862 | 0e+00 | 0e+00 | 34 |
GO:0032989 | cellular component morphogenesis | 51/553 | 766/18862 | 0e+00 | 0e+00 | 51 |
GO:0099177 | regulation of trans-synaptic signaling | 34/553 | 406/18862 | 0e+00 | 0e+00 | 34 |
GO:0045766 | positive regulation of angiogenesis | 21/553 | 175/18862 | 0e+00 | 0e+00 | 21 |
GO:1904018 | positive regulation of vasculature development | 21/553 | 175/18862 | 0e+00 | 0e+00 | 21 |
GO:0050900 | leukocyte migration | 39/553 | 509/18862 | 0e+00 | 0e+00 | 39 |
GO:0032526 | response to retinoic acid | 16/553 | 103/18862 | 0e+00 | 0e+00 | 16 |
GO:0090257 | regulation of muscle system process | 25/553 | 243/18862 | 0e+00 | 0e+00 | 25 |
GO:1901653 | cellular response to peptide | 33/553 | 391/18862 | 0e+00 | 0e+00 | 33 |
GO:0043408 | regulation of MAPK cascade | 48/553 | 708/18862 | 0e+00 | 0e+00 | 48 |
GO:0007548 | sex differentiation | 26/553 | 262/18862 | 0e+00 | 0e+00 | 26 |
GO:0042060 | wound healing | 40/553 | 535/18862 | 0e+00 | 0e+00 | 40 |
GO:0033674 | positive regulation of kinase activity | 43/553 | 601/18862 | 0e+00 | 0e+00 | 43 |
GO:0009991 | response to extracellular stimulus | 37/553 | 477/18862 | 0e+00 | 0e+00 | 37 |
GO:0048589 | developmental growth | 43/553 | 605/18862 | 0e+00 | 0e+00 | 43 |
GO:0051272 | positive regulation of cellular component movement | 42/553 | 585/18862 | 0e+00 | 0e+00 | 42 |
GO:0040017 | positive regulation of locomotion | 42/553 | 586/18862 | 0e+00 | 0e+00 | 42 |
GO:0050801 | ion homeostasis | 51/553 | 787/18862 | 0e+00 | 0e+00 | 51 |
GO:0031175 | neuron projection development | 59/553 | 977/18862 | 0e+00 | 0e+00 | 59 |
GO:0008544 | epidermis development | 36/553 | 463/18862 | 0e+00 | 0e+00 | 36 |
GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 19/553 | 154/18862 | 0e+00 | 0e+00 | 19 |
GO:0048608 | reproductive structure development | 33/553 | 405/18862 | 0e+00 | 0e+00 | 33 |
GO:2000147 | positive regulation of cell motility | 41/553 | 573/18862 | 0e+00 | 0e+00 | 41 |
GO:2001233 | regulation of apoptotic signaling pathway | 30/553 | 348/18862 | 0e+00 | 0e+00 | 30 |
GO:0061458 | reproductive system development | 33/553 | 408/18862 | 0e+00 | 0e+00 | 33 |
GO:0045776 | negative regulation of blood pressure | 10/553 | 40/18862 | 0e+00 | 0e+00 | 10 |
GO:0003180 | aortic valve morphogenesis | 9/553 | 31/18862 | 0e+00 | 0e+00 | 9 |
GO:0007507 | heart development | 40/553 | 555/18862 | 0e+00 | 0e+00 | 40 |
GO:0007423 | sensory organ development | 39/553 | 534/18862 | 0e+00 | 0e+00 | 39 |
GO:0051047 | positive regulation of secretion | 27/553 | 295/18862 | 0e+00 | 0e+00 | 27 |
GO:0009790 | embryo development | 59/553 | 992/18862 | 0e+00 | 0e+00 | 59 |
GO:0032880 | regulation of protein localization | 54/553 | 875/18862 | 0e+00 | 0e+00 | 54 |
GO:0006941 | striated muscle contraction | 20/553 | 176/18862 | 0e+00 | 0e+00 | 20 |
GO:0051098 | regulation of binding | 30/553 | 357/18862 | 0e+00 | 0e+00 | 30 |
GO:0048534 | hematopoietic or lymphoid organ development | 56/553 | 932/18862 | 0e+00 | 0e+00 | 56 |
GO:0071300 | cellular response to retinoic acid | 12/553 | 64/18862 | 0e+00 | 0e+00 | 12 |
GO:0042593 | glucose homeostasis | 23/553 | 229/18862 | 0e+00 | 0e+00 | 23 |
GO:0036293 | response to decreased oxygen levels | 30/553 | 360/18862 | 0e+00 | 0e+00 | 30 |
GO:0048729 | tissue morphogenesis | 43/553 | 634/18862 | 0e+00 | 0e+00 | 43 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 15/553 | 103/18862 | 0e+00 | 0e+00 | 15 |
GO:0033500 | carbohydrate homeostasis | 23/553 | 230/18862 | 0e+00 | 0e+00 | 23 |
GO:0030879 | mammary gland development | 17/553 | 132/18862 | 0e+00 | 0e+00 | 17 |
GO:0007568 | aging | 27/553 | 304/18862 | 0e+00 | 0e+00 | 27 |
GO:0045860 | positive regulation of protein kinase activity | 38/553 | 528/18862 | 0e+00 | 0e+00 | 38 |
GO:0051480 | regulation of cytosolic calcium ion concentration | 29/553 | 344/18862 | 0e+00 | 0e+00 | 29 |
GO:0006942 | regulation of striated muscle contraction | 14/553 | 91/18862 | 0e+00 | 0e+00 | 14 |
GO:0032496 | response to lipopolysaccharide | 28/553 | 326/18862 | 0e+00 | 0e+00 | 28 |
GO:0002237 | response to molecule of bacterial origin | 29/553 | 346/18862 | 0e+00 | 0e+00 | 29 |
GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 23/553 | 234/18862 | 0e+00 | 0e+00 | 23 |
GO:1903532 | positive regulation of secretion by cell | 25/553 | 271/18862 | 0e+00 | 0e+00 | 25 |
GO:0001666 | response to hypoxia | 29/553 | 348/18862 | 0e+00 | 0e+00 | 29 |
GO:0048880 | sensory system development | 30/553 | 369/18862 | 0e+00 | 0e+00 | 30 |
GO:0031960 | response to corticosteroid | 18/553 | 152/18862 | 0e+00 | 0e+00 | 18 |
GO:1903037 | regulation of leukocyte cell-cell adhesion | 28/553 | 330/18862 | 0e+00 | 0e+00 | 28 |
GO:0009612 | response to mechanical stimulus | 21/553 | 202/18862 | 0e+00 | 0e+00 | 21 |
GO:0015837 | amine transport | 14/553 | 94/18862 | 0e+00 | 0e+00 | 14 |
GO:0050679 | positive regulation of epithelial cell proliferation | 21/553 | 203/18862 | 0e+00 | 0e+00 | 21 |
GO:0003176 | aortic valve development | 9/553 | 36/18862 | 0e+00 | 0e+00 | 9 |
GO:0045765 | regulation of angiogenesis | 28/553 | 335/18862 | 0e+00 | 0e+00 | 28 |
GO:0001656 | metanephros development | 13/553 | 82/18862 | 0e+00 | 0e+00 | 13 |
GO:0000165 | MAPK cascade | 54/553 | 913/18862 | 0e+00 | 0e+00 | 54 |
GO:0032355 | response to estradiol | 16/553 | 125/18862 | 0e+00 | 0e+00 | 16 |
GO:2001234 | negative regulation of apoptotic signaling pathway | 22/553 | 224/18862 | 0e+00 | 0e+00 | 22 |
GO:0061138 | morphogenesis of a branching epithelium | 19/553 | 173/18862 | 0e+00 | 0e+00 | 19 |
GO:0030073 | insulin secretion | 21/553 | 207/18862 | 0e+00 | 0e+00 | 21 |
GO:0002520 | immune system development | 57/553 | 989/18862 | 0e+00 | 0e+00 | 57 |
GO:0030097 | hemopoiesis | 53/553 | 892/18862 | 0e+00 | 0e+00 | 53 |
GO:0001654 | eye development | 29/553 | 359/18862 | 0e+00 | 0e+00 | 29 |
GO:0030335 | positive regulation of cell migration | 38/553 | 549/18862 | 0e+00 | 0e+00 | 38 |
GO:0051223 | regulation of protein transport | 38/553 | 549/18862 | 0e+00 | 0e+00 | 38 |
GO:0035296 | regulation of tube diameter | 16/553 | 127/18862 | 0e+00 | 0e+00 | 16 |
GO:0097746 | blood vessel diameter maintenance | 16/553 | 127/18862 | 0e+00 | 0e+00 | 16 |
GO:0048771 | tissue remodeling | 19/553 | 175/18862 | 0e+00 | 0e+00 | 19 |
GO:1901342 | regulation of vasculature development | 28/553 | 341/18862 | 0e+00 | 0e+00 | 28 |
GO:0051090 | regulation of DNA-binding transcription factor activity | 33/553 | 444/18862 | 0e+00 | 0e+00 | 33 |
GO:0035150 | regulation of tube size | 16/553 | 128/18862 | 0e+00 | 0e+00 | 16 |
GO:0032870 | cellular response to hormone stimulus | 41/553 | 619/18862 | 0e+00 | 0e+00 | 41 |
GO:0150063 | visual system development | 29/553 | 363/18862 | 0e+00 | 0e+00 | 29 |
GO:0008217 | regulation of blood pressure | 19/553 | 177/18862 | 0e+00 | 0e+00 | 19 |
GO:0040008 | regulation of growth | 42/553 | 644/18862 | 0e+00 | 0e+00 | 42 |
GO:0007589 | body fluid secretion | 13/553 | 86/18862 | 0e+00 | 0e+00 | 13 |
GO:0051952 | regulation of amine transport | 13/553 | 86/18862 | 0e+00 | 0e+00 | 13 |
GO:0046683 | response to organophosphorus | 16/553 | 130/18862 | 0e+00 | 0e+00 | 16 |
GO:0032635 | interleukin-6 production | 18/553 | 162/18862 | 0e+00 | 0e+00 | 18 |
GO:0019932 | second-messenger-mediated signaling | 26/553 | 307/18862 | 0e+00 | 0e+00 | 26 |
GO:0071407 | cellular response to organic cyclic compound | 38/553 | 558/18862 | 0e+00 | 0e+00 | 38 |
GO:0043010 | camera-type eye development | 26/553 | 310/18862 | 0e+00 | 0e+00 | 26 |
GO:0071214 | cellular response to abiotic stimulus | 27/553 | 330/18862 | 0e+00 | 0e+00 | 27 |
GO:0104004 | cellular response to environmental stimulus | 27/553 | 330/18862 | 0e+00 | 0e+00 | 27 |
GO:0030334 | regulation of cell migration | 55/553 | 962/18862 | 0e+00 | 0e+00 | 55 |
GO:0097191 | extrinsic apoptotic signaling pathway | 21/553 | 217/18862 | 0e+00 | 0e+00 | 21 |
GO:0034762 | regulation of transmembrane transport | 38/553 | 565/18862 | 0e+00 | 0e+00 | 38 |
GO:0051347 | positive regulation of transferase activity | 43/553 | 679/18862 | 0e+00 | 0e+00 | 43 |
GO:0043434 | response to peptide hormone | 32/553 | 435/18862 | 0e+00 | 0e+00 | 32 |
GO:0043588 | skin development | 31/553 | 415/18862 | 0e+00 | 1e-04 | 31 |
GO:0035249 | synaptic transmission, glutamatergic | 13/553 | 90/18862 | 0e+00 | 1e-04 | 13 |
GO:0051384 | response to glucocorticoid | 16/553 | 135/18862 | 0e+00 | 1e-04 | 16 |
GO:0060048 | cardiac muscle contraction | 16/553 | 135/18862 | 0e+00 | 1e-04 | 16 |
GO:1905314 | semi-lunar valve development | 9/553 | 41/18862 | 0e+00 | 1e-04 | 9 |
GO:0042129 | regulation of T cell proliferation | 18/553 | 168/18862 | 0e+00 | 1e-04 | 18 |
GO:0050670 | regulation of lymphocyte proliferation | 21/553 | 221/18862 | 0e+00 | 1e-04 | 21 |
GO:0001763 | morphogenesis of a branching structure | 19/553 | 186/18862 | 0e+00 | 1e-04 | 19 |
GO:0044706 | multi-multicellular organism process | 20/553 | 204/18862 | 0e+00 | 1e-04 | 20 |
GO:0050708 | regulation of protein secretion | 24/553 | 279/18862 | 0e+00 | 1e-04 | 24 |
GO:0032944 | regulation of mononuclear cell proliferation | 21/553 | 223/18862 | 0e+00 | 1e-04 | 21 |
GO:0070201 | regulation of establishment of protein localization | 38/553 | 574/18862 | 0e+00 | 1e-04 | 38 |
GO:0030001 | metal ion transport | 34/553 | 486/18862 | 0e+00 | 1e-04 | 34 |
GO:0051093 | negative regulation of developmental process | 53/553 | 929/18862 | 0e+00 | 1e-04 | 53 |
GO:0035270 | endocrine system development | 15/553 | 122/18862 | 0e+00 | 1e-04 | 15 |
GO:0009913 | epidermal cell differentiation | 28/553 | 360/18862 | 0e+00 | 1e-04 | 28 |
GO:0061448 | connective tissue development | 22/553 | 243/18862 | 0e+00 | 1e-04 | 22 |
GO:0051591 | response to cAMP | 13/553 | 93/18862 | 0e+00 | 1e-04 | 13 |
GO:0002064 | epithelial cell development | 20/553 | 207/18862 | 0e+00 | 1e-04 | 20 |
GO:0042476 | odontogenesis | 15/553 | 123/18862 | 0e+00 | 1e-04 | 15 |
GO:0032409 | regulation of transporter activity | 24/553 | 283/18862 | 0e+00 | 1e-04 | 24 |
GO:0008016 | regulation of heart contraction | 22/553 | 245/18862 | 0e+00 | 1e-04 | 22 |
GO:0006836 | neurotransmitter transport | 20/553 | 209/18862 | 0e+00 | 1e-04 | 20 |
GO:0051954 | positive regulation of amine transport | 8/553 | 33/18862 | 0e+00 | 1e-04 | 8 |
GO:0031099 | regeneration | 19/553 | 192/18862 | 0e+00 | 1e-04 | 19 |
GO:0034330 | cell junction organization | 43/553 | 699/18862 | 0e+00 | 1e-04 | 43 |
GO:0050727 | regulation of inflammatory response | 28/553 | 366/18862 | 0e+00 | 1e-04 | 28 |
GO:0006816 | calcium ion transport | 30/553 | 409/18862 | 0e+00 | 1e-04 | 30 |
GO:0060485 | mesenchyme development | 24/553 | 287/18862 | 0e+00 | 1e-04 | 24 |
GO:0022898 | regulation of transmembrane transporter activity | 23/553 | 268/18862 | 0e+00 | 1e-04 | 23 |
GO:0071363 | cellular response to growth factor stimulus | 43/553 | 703/18862 | 0e+00 | 1e-04 | 43 |
GO:0048754 | branching morphogenesis of an epithelial tube | 16/553 | 143/18862 | 0e+00 | 1e-04 | 16 |
GO:0001816 | cytokine production | 48/553 | 823/18862 | 0e+00 | 1e-04 | 48 |
GO:1901385 | regulation of voltage-gated calcium channel activity | 8/553 | 34/18862 | 0e+00 | 1e-04 | 8 |
GO:0051966 | regulation of synaptic transmission, glutamatergic | 11/553 | 69/18862 | 0e+00 | 1e-04 | 11 |
GO:0050728 | negative regulation of inflammatory response | 17/553 | 160/18862 | 0e+00 | 1e-04 | 17 |
GO:0003015 | heart process | 24/553 | 289/18862 | 0e+00 | 1e-04 | 24 |
GO:0014074 | response to purine-containing compound | 16/553 | 144/18862 | 0e+00 | 1e-04 | 16 |
GO:0050796 | regulation of insulin secretion | 18/553 | 178/18862 | 0e+00 | 1e-04 | 18 |
GO:0007204 | positive regulation of cytosolic calcium ion concentration | 25/553 | 310/18862 | 0e+00 | 1e-04 | 25 |
GO:0018105 | peptidyl-serine phosphorylation | 25/553 | 310/18862 | 0e+00 | 1e-04 | 25 |
GO:0097305 | response to alcohol | 21/553 | 233/18862 | 0e+00 | 1e-04 | 21 |
GO:0070848 | response to growth factor | 44/553 | 732/18862 | 0e+00 | 1e-04 | 44 |
GO:0019221 | cytokine-mediated signaling pathway | 47/553 | 804/18862 | 0e+00 | 1e-04 | 47 |
GO:0097094 | craniofacial suture morphogenesis | 6/553 | 17/18862 | 0e+00 | 1e-04 | 6 |
GO:0018209 | peptidyl-serine modification | 26/553 | 333/18862 | 0e+00 | 1e-04 | 26 |
GO:0072073 | kidney epithelium development | 15/553 | 131/18862 | 0e+00 | 1e-04 | 15 |
GO:0006939 | smooth muscle contraction | 13/553 | 100/18862 | 0e+00 | 1e-04 | 13 |
GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway | 7/553 | 26/18862 | 0e+00 | 1e-04 | 7 |
GO:0007584 | response to nutrient | 17/553 | 165/18862 | 0e+00 | 1e-04 | 17 |
GO:0032755 | positive regulation of interleukin-6 production | 12/553 | 86/18862 | 0e+00 | 2e-04 | 12 |
GO:0042311 | vasodilation | 8/553 | 36/18862 | 0e+00 | 2e-04 | 8 |
GO:0051924 | regulation of calcium ion transport | 21/553 | 238/18862 | 0e+00 | 2e-04 | 21 |
GO:0070663 | regulation of leukocyte proliferation | 21/553 | 241/18862 | 0e+00 | 2e-04 | 21 |
GO:0009314 | response to radiation | 31/553 | 447/18862 | 0e+00 | 2e-04 | 31 |
GO:0051928 | positive regulation of calcium ion transport | 14/553 | 118/18862 | 0e+00 | 2e-04 | 14 |
GO:0034765 | regulation of ion transmembrane transport | 36/553 | 560/18862 | 0e+00 | 2e-04 | 36 |
GO:0030216 | keratinocyte differentiation | 24/553 | 302/18862 | 0e+00 | 2e-04 | 24 |
GO:0042063 | gliogenesis | 23/553 | 283/18862 | 0e+00 | 2e-04 | 23 |
GO:0055117 | regulation of cardiac muscle contraction | 11/553 | 75/18862 | 0e+00 | 2e-04 | 11 |
GO:0070252 | actin-mediated cell contraction | 14/553 | 120/18862 | 0e+00 | 2e-04 | 14 |
GO:0042110 | T cell activation | 32/553 | 474/18862 | 0e+00 | 2e-04 | 32 |
GO:0010035 | response to inorganic substance | 35/553 | 542/18862 | 0e+00 | 2e-04 | 35 |
GO:0045664 | regulation of neuron differentiation | 18/553 | 190/18862 | 0e+00 | 2e-04 | 18 |
GO:0010959 | regulation of metal ion transport | 21/553 | 247/18862 | 0e+00 | 3e-04 | 21 |
GO:0008361 | regulation of cell size | 17/553 | 173/18862 | 0e+00 | 3e-04 | 17 |
GO:0003006 | developmental process involved in reproduction | 52/553 | 957/18862 | 0e+00 | 3e-04 | 52 |
GO:0045989 | positive regulation of striated muscle contraction | 5/553 | 12/18862 | 0e+00 | 3e-04 | 5 |
GO:0045933 | positive regulation of muscle contraction | 8/553 | 39/18862 | 0e+00 | 3e-04 | 8 |
GO:0050832 | defense response to fungus | 8/553 | 39/18862 | 0e+00 | 3e-04 | 8 |
GO:0031669 | cellular response to nutrient levels | 19/553 | 210/18862 | 0e+00 | 3e-04 | 19 |
GO:0098660 | inorganic ion transmembrane transport | 48/553 | 860/18862 | 0e+00 | 3e-04 | 48 |
GO:0060562 | epithelial tube morphogenesis | 24/553 | 309/18862 | 0e+00 | 3e-04 | 24 |
GO:0001819 | positive regulation of cytokine production | 30/553 | 437/18862 | 0e+00 | 3e-04 | 30 |
GO:0060348 | bone development | 18/553 | 193/18862 | 0e+00 | 3e-04 | 18 |
GO:0032102 | negative regulation of response to external stimulus | 28/553 | 394/18862 | 0e+00 | 3e-04 | 28 |
GO:0007623 | circadian rhythm | 19/553 | 212/18862 | 0e+00 | 3e-04 | 19 |
GO:0050870 | positive regulation of T cell activation | 19/553 | 212/18862 | 0e+00 | 3e-04 | 19 |
GO:0048762 | mesenchymal cell differentiation | 20/553 | 231/18862 | 0e+00 | 3e-04 | 20 |
GO:0046887 | positive regulation of hormone secretion | 14/553 | 124/18862 | 0e+00 | 3e-04 | 14 |
GO:1904064 | positive regulation of cation transmembrane transport | 15/553 | 141/18862 | 0e+00 | 3e-04 | 15 |
GO:0045165 | cell fate commitment | 21/553 | 251/18862 | 0e+00 | 3e-04 | 21 |
GO:0071560 | cellular response to transforming growth factor beta stimulus | 21/553 | 251/18862 | 0e+00 | 3e-04 | 21 |
GO:0032735 | positive regulation of interleukin-12 production | 8/553 | 40/18862 | 0e+00 | 3e-04 | 8 |
GO:0046717 | acid secretion | 8/553 | 40/18862 | 0e+00 | 3e-04 | 8 |
GO:0031103 | axon regeneration | 9/553 | 52/18862 | 0e+00 | 3e-04 | 9 |
GO:0060284 | regulation of cell development | 32/553 | 485/18862 | 0e+00 | 3e-04 | 32 |
GO:0042098 | T cell proliferation | 18/553 | 195/18862 | 0e+00 | 3e-04 | 18 |
GO:0015844 | monoamine transport | 11/553 | 79/18862 | 0e+00 | 3e-04 | 11 |
GO:0007565 | female pregnancy | 17/553 | 177/18862 | 0e+00 | 3e-04 | 17 |
GO:0043393 | regulation of protein binding | 18/553 | 196/18862 | 0e+00 | 3e-04 | 18 |
GO:0007601 | visual perception | 19/553 | 215/18862 | 0e+00 | 3e-04 | 19 |
GO:0002009 | morphogenesis of an epithelium | 34/553 | 533/18862 | 0e+00 | 3e-04 | 34 |
GO:0003179 | heart valve morphogenesis | 9/553 | 53/18862 | 0e+00 | 4e-04 | 9 |
GO:0009620 | response to fungus | 9/553 | 53/18862 | 0e+00 | 4e-04 | 9 |
GO:0010332 | response to gamma radiation | 9/553 | 53/18862 | 0e+00 | 4e-04 | 9 |
GO:0009268 | response to pH | 8/553 | 41/18862 | 0e+00 | 4e-04 | 8 |
GO:0032602 | chemokine production | 12/553 | 95/18862 | 0e+00 | 4e-04 | 12 |
GO:0090277 | positive regulation of peptide hormone secretion | 12/553 | 95/18862 | 0e+00 | 4e-04 | 12 |
GO:0009617 | response to bacterium | 42/553 | 724/18862 | 0e+00 | 4e-04 | 42 |
GO:0007369 | gastrulation | 17/553 | 179/18862 | 0e+00 | 4e-04 | 17 |
GO:0050806 | positive regulation of synaptic transmission | 15/553 | 144/18862 | 0e+00 | 4e-04 | 15 |
GO:0001503 | ossification | 28/553 | 401/18862 | 0e+00 | 4e-04 | 28 |
GO:0045137 | development of primary sexual characteristics | 19/553 | 217/18862 | 0e+00 | 4e-04 | 19 |
GO:0033555 | multicellular organismal response to stress | 10/553 | 67/18862 | 0e+00 | 4e-04 | 10 |
GO:1903169 | regulation of calcium ion transmembrane transport | 15/553 | 145/18862 | 0e+00 | 4e-04 | 15 |
GO:0071559 | response to transforming growth factor beta | 21/553 | 257/18862 | 0e+00 | 4e-04 | 21 |
GO:0031670 | cellular response to nutrient | 8/553 | 42/18862 | 0e+00 | 4e-04 | 8 |
GO:0071875 | adrenergic receptor signaling pathway | 7/553 | 31/18862 | 0e+00 | 4e-04 | 7 |
GO:0048638 | regulation of developmental growth | 24/553 | 319/18862 | 0e+00 | 4e-04 | 24 |
GO:1904062 | regulation of cation transmembrane transport | 25/553 | 340/18862 | 0e+00 | 4e-04 | 25 |
GO:0032868 | response to insulin | 22/553 | 278/18862 | 0e+00 | 4e-04 | 22 |
GO:0050953 | sensory perception of light stimulus | 19/553 | 219/18862 | 0e+00 | 4e-04 | 19 |
GO:0003007 | heart morphogenesis | 20/553 | 239/18862 | 0e+00 | 4e-04 | 20 |
GO:0043549 | regulation of kinase activity | 49/553 | 905/18862 | 0e+00 | 4e-04 | 49 |
GO:0060047 | heart contraction | 22/553 | 279/18862 | 0e+00 | 4e-04 | 22 |
GO:0001817 | regulation of cytokine production | 44/553 | 781/18862 | 0e+00 | 4e-04 | 44 |
GO:0070997 | neuron death | 25/553 | 342/18862 | 0e+00 | 4e-04 | 25 |
GO:1901019 | regulation of calcium ion transmembrane transporter activity | 11/553 | 83/18862 | 0e+00 | 5e-04 | 11 |
GO:0072243 | metanephric nephron epithelium development | 6/553 | 22/18862 | 0e+00 | 5e-04 | 6 |
GO:0035637 | multicellular organismal signaling | 18/553 | 203/18862 | 0e+00 | 5e-04 | 18 |
GO:0046651 | lymphocyte proliferation | 22/553 | 282/18862 | 0e+00 | 5e-04 | 22 |
GO:0019233 | sensory perception of pain | 12/553 | 99/18862 | 0e+00 | 5e-04 | 12 |
GO:0042102 | positive regulation of T cell proliferation | 12/553 | 99/18862 | 0e+00 | 5e-04 | 12 |
GO:0071496 | cellular response to external stimulus | 23/553 | 303/18862 | 0e+00 | 5e-04 | 23 |
GO:0051216 | cartilage development | 17/553 | 185/18862 | 0e+00 | 5e-04 | 17 |
GO:0030048 | actin filament-based movement | 15/553 | 150/18862 | 0e+00 | 6e-04 | 15 |
GO:0090596 | sensory organ morphogenesis | 20/553 | 244/18862 | 0e+00 | 6e-04 | 20 |
GO:0032943 | mononuclear cell proliferation | 22/553 | 285/18862 | 0e+00 | 6e-04 | 22 |
GO:0050863 | regulation of T cell activation | 24/553 | 327/18862 | 0e+00 | 6e-04 | 24 |
GO:0045926 | negative regulation of growth | 20/553 | 245/18862 | 0e+00 | 6e-04 | 20 |
GO:0002793 | positive regulation of peptide secretion | 15/553 | 151/18862 | 0e+00 | 6e-04 | 15 |
GO:0021536 | diencephalon development | 10/553 | 71/18862 | 0e+00 | 6e-04 | 10 |
GO:0034764 | positive regulation of transmembrane transport | 18/553 | 207/18862 | 0e+00 | 6e-04 | 18 |
GO:0034767 | positive regulation of ion transmembrane transport | 18/553 | 207/18862 | 0e+00 | 6e-04 | 18 |
GO:0045859 | regulation of protein kinase activity | 44/553 | 794/18862 | 0e+00 | 6e-04 | 44 |
GO:0051051 | negative regulation of transport | 29/553 | 438/18862 | 0e+00 | 6e-04 | 29 |
GO:0051101 | regulation of DNA binding | 13/553 | 118/18862 | 0e+00 | 6e-04 | 13 |
GO:0050671 | positive regulation of lymphocyte proliferation | 14/553 | 135/18862 | 0e+00 | 6e-04 | 14 |
GO:0031102 | neuron projection regeneration | 9/553 | 58/18862 | 0e+00 | 7e-04 | 9 |
GO:0061005 | cell differentiation involved in kidney development | 9/553 | 58/18862 | 0e+00 | 7e-04 | 9 |
GO:0009266 | response to temperature stimulus | 19/553 | 228/18862 | 0e+00 | 7e-04 | 19 |
GO:0001501 | skeletal system development | 31/553 | 486/18862 | 0e+00 | 7e-04 | 31 |
GO:0045229 | external encapsulating structure organization | 27/553 | 396/18862 | 0e+00 | 7e-04 | 27 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 14/553 | 136/18862 | 0e+00 | 7e-04 | 14 |
GO:0035137 | hindlimb morphogenesis | 7/553 | 34/18862 | 0e+00 | 7e-04 | 7 |
GO:0060428 | lung epithelium development | 7/553 | 34/18862 | 0e+00 | 7e-04 | 7 |
GO:1902107 | positive regulation of leukocyte differentiation | 15/553 | 154/18862 | 0e+00 | 7e-04 | 15 |
GO:1903708 | positive regulation of hemopoiesis | 15/553 | 154/18862 | 0e+00 | 7e-04 | 15 |
GO:0010720 | positive regulation of cell development | 22/553 | 290/18862 | 0e+00 | 7e-04 | 22 |
GO:0010001 | glial cell differentiation | 18/553 | 210/18862 | 0e+00 | 7e-04 | 18 |
GO:0051402 | neuron apoptotic process | 19/553 | 230/18862 | 1e-04 | 7e-04 | 19 |
GO:0098657 | import into cell | 19/553 | 230/18862 | 1e-04 | 7e-04 | 19 |
GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 9/553 | 59/18862 | 1e-04 | 7e-04 | 9 |
GO:0060249 | anatomical structure homeostasis | 30/553 | 466/18862 | 1e-04 | 7e-04 | 30 |
GO:0001505 | regulation of neurotransmitter levels | 18/553 | 211/18862 | 1e-04 | 7e-04 | 18 |
GO:0060037 | pharyngeal system development | 6/553 | 24/18862 | 1e-04 | 7e-04 | 6 |
GO:0048863 | stem cell differentiation | 20/553 | 251/18862 | 1e-04 | 8e-04 | 20 |
GO:0008406 | gonad development | 18/553 | 212/18862 | 1e-04 | 8e-04 | 18 |
GO:0009755 | hormone-mediated signaling pathway | 17/553 | 193/18862 | 1e-04 | 8e-04 | 17 |
GO:0032642 | regulation of chemokine production | 11/553 | 89/18862 | 1e-04 | 8e-04 | 11 |
GO:0051129 | negative regulation of cellular component organization | 41/553 | 731/18862 | 1e-04 | 8e-04 | 41 |
GO:0032615 | interleukin-12 production | 9/553 | 60/18862 | 1e-04 | 8e-04 | 9 |
GO:0032655 | regulation of interleukin-12 production | 9/553 | 60/18862 | 1e-04 | 8e-04 | 9 |
GO:0046888 | negative regulation of hormone secretion | 9/553 | 60/18862 | 1e-04 | 8e-04 | 9 |
GO:0018149 | peptide cross-linking | 7/553 | 35/18862 | 1e-04 | 8e-04 | 7 |
GO:0006959 | humoral immune response | 26/553 | 380/18862 | 1e-04 | 8e-04 | 26 |
GO:0072009 | nephron epithelium development | 12/553 | 106/18862 | 1e-04 | 9e-04 | 12 |
GO:1905114 | cell surface receptor signaling pathway involved in cell-cell signaling | 36/553 | 613/18862 | 1e-04 | 9e-04 | 36 |
GO:0032675 | regulation of interleukin-6 production | 15/553 | 158/18862 | 1e-04 | 9e-04 | 15 |
GO:0007517 | muscle organ development | 23/553 | 317/18862 | 1e-04 | 9e-04 | 23 |
GO:0003170 | heart valve development | 9/553 | 61/18862 | 1e-04 | 9e-04 | 9 |
GO:0032682 | negative regulation of chemokine production | 6/553 | 25/18862 | 1e-04 | 9e-04 | 6 |
GO:0072202 | cell differentiation involved in metanephros development | 6/553 | 25/18862 | 1e-04 | 9e-04 | 6 |
GO:0072207 | metanephric epithelium development | 6/553 | 25/18862 | 1e-04 | 9e-04 | 6 |
GO:0031668 | cellular response to extracellular stimulus | 19/553 | 235/18862 | 1e-04 | 9e-04 | 19 |
GO:0035850 | epithelial cell differentiation involved in kidney development | 8/553 | 48/18862 | 1e-04 | 9e-04 | 8 |
GO:0045596 | negative regulation of cell differentiation | 38/553 | 664/18862 | 1e-04 | 9e-04 | 38 |
GO:0060341 | regulation of cellular localization | 44/553 | 813/18862 | 1e-04 | 9e-04 | 44 |
GO:0031348 | negative regulation of defense response | 19/553 | 236/18862 | 1e-04 | 1e-03 | 19 |
GO:0032412 | regulation of ion transmembrane transporter activity | 20/553 | 257/18862 | 1e-04 | 1e-03 | 20 |
GO:0031214 | biomineral tissue development | 15/553 | 160/18862 | 1e-04 | 1e-03 | 15 |
GO:0048660 | regulation of smooth muscle cell proliferation | 15/553 | 160/18862 | 1e-04 | 1e-03 | 15 |
GO:0019730 | antimicrobial humoral response | 14/553 | 142/18862 | 1e-04 | 1e-03 | 14 |
ID | Description | GeneRatio | BgRatio | pvalue | p.adjust | Count |
---|---|---|---|---|---|---|
GO:0016071 | mRNA metabolic process | 52/350 | 882/18862 | 0 | 0e+00 | 52 |
GO:1903311 | regulation of mRNA metabolic process | 30/350 | 334/18862 | 0 | 0e+00 | 30 |
GO:0016579 | protein deubiquitination | 26/350 | 283/18862 | 0 | 0e+00 | 26 |
GO:0000375 | RNA splicing, via transesterification reactions | 30/350 | 386/18862 | 0 | 0e+00 | 30 |
GO:0044403 | biological process involved in symbiotic interaction | 51/350 | 1000/18862 | 0 | 0e+00 | 51 |
GO:0016032 | viral process | 49/350 | 942/18862 | 0 | 0e+00 | 49 |
GO:0070646 | protein modification by small protein removal | 26/350 | 300/18862 | 0 | 0e+00 | 26 |
GO:0044257 | cellular protein catabolic process | 44/350 | 797/18862 | 0 | 0e+00 | 44 |
GO:0008380 | RNA splicing | 33/350 | 481/18862 | 0 | 0e+00 | 33 |
GO:0045786 | negative regulation of cell cycle | 38/350 | 624/18862 | 0 | 0e+00 | 38 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 29/350 | 383/18862 | 0 | 0e+00 | 29 |
GO:0000398 | mRNA splicing, via spliceosome | 29/350 | 383/18862 | 0 | 0e+00 | 29 |
GO:0006397 | mRNA processing | 35/350 | 546/18862 | 0 | 0e+00 | 35 |
GO:0006119 | oxidative phosphorylation | 18/350 | 148/18862 | 0 | 0e+00 | 18 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 16/350 | 115/18862 | 0 | 0e+00 | 16 |
GO:0031329 | regulation of cellular catabolic process | 44/350 | 848/18862 | 0 | 0e+00 | 44 |
GO:0030163 | protein catabolic process | 47/350 | 948/18862 | 0 | 0e+00 | 47 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 13/350 | 77/18862 | 0 | 0e+00 | 13 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 15/350 | 109/18862 | 0 | 0e+00 | 15 |
GO:0043488 | regulation of mRNA stability | 19/350 | 188/18862 | 0 | 0e+00 | 19 |
GO:0043487 | regulation of RNA stability | 19/350 | 198/18862 | 0 | 0e+00 | 19 |
GO:0043632 | modification-dependent macromolecule catabolic process | 36/350 | 656/18862 | 0 | 0e+00 | 36 |
GO:0032446 | protein modification by small protein conjugation | 45/350 | 958/18862 | 0 | 0e+00 | 45 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 35/350 | 639/18862 | 0 | 0e+00 | 35 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 38/350 | 735/18862 | 0 | 0e+00 | 38 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 14/350 | 108/18862 | 0 | 0e+00 | 14 |
GO:0045333 | cellular respiration | 18/350 | 187/18862 | 0 | 0e+00 | 18 |
GO:0061013 | regulation of mRNA catabolic process | 19/350 | 210/18862 | 0 | 0e+00 | 19 |
GO:0019941 | modification-dependent protein catabolic process | 35/350 | 645/18862 | 0 | 0e+00 | 35 |
GO:0016567 | protein ubiquitination | 42/350 | 874/18862 | 0 | 0e+00 | 42 |
GO:0006521 | regulation of cellular amino acid metabolic process | 11/350 | 62/18862 | 0 | 0e+00 | 11 |
GO:0090175 | regulation of establishment of planar polarity | 14/350 | 112/18862 | 0 | 0e+00 | 14 |
GO:0022904 | respiratory electron transport chain | 14/350 | 117/18862 | 0 | 0e+00 | 14 |
GO:0001736 | establishment of planar polarity | 14/350 | 123/18862 | 0 | 0e+00 | 14 |
GO:0007164 | establishment of tissue polarity | 14/350 | 123/18862 | 0 | 0e+00 | 14 |
GO:0006913 | nucleocytoplasmic transport | 23/350 | 340/18862 | 0 | 0e+00 | 23 |
GO:1902036 | regulation of hematopoietic stem cell differentiation | 11/350 | 74/18862 | 0 | 0e+00 | 11 |
GO:0010498 | proteasomal protein catabolic process | 28/350 | 483/18862 | 0 | 0e+00 | 28 |
GO:0051169 | nuclear transport | 23/350 | 343/18862 | 0 | 0e+00 | 23 |
GO:0033238 | regulation of cellular amine metabolic process | 11/350 | 77/18862 | 0 | 0e+00 | 11 |
GO:0006091 | generation of precursor metabolites and energy | 29/350 | 524/18862 | 0 | 0e+00 | 29 |
GO:0022900 | electron transport chain | 16/350 | 178/18862 | 0 | 0e+00 | 16 |
GO:0006401 | RNA catabolic process | 25/350 | 414/18862 | 0 | 0e+00 | 25 |
GO:0015980 | energy derivation by oxidation of organic compounds | 20/350 | 278/18862 | 0 | 0e+00 | 20 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 12/350 | 100/18862 | 0 | 0e+00 | 12 |
GO:0031145 | anaphase-promoting complex-dependent catabolic process | 11/350 | 83/18862 | 0 | 0e+00 | 11 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 16/350 | 185/18862 | 0 | 0e+00 | 16 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 25/350 | 425/18862 | 0 | 0e+00 | 25 |
GO:0046034 | ATP metabolic process | 21/350 | 313/18862 | 0 | 0e+00 | 21 |
GO:0001738 | morphogenesis of a polarized epithelium | 14/350 | 144/18862 | 0 | 0e+00 | 14 |
GO:0060218 | hematopoietic stem cell differentiation | 11/350 | 88/18862 | 0 | 1e-04 | 11 |
GO:0048002 | antigen processing and presentation of peptide antigen | 16/350 | 194/18862 | 0 | 1e-04 | 16 |
GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 11/350 | 89/18862 | 0 | 1e-04 | 11 |
GO:0080135 | regulation of cellular response to stress | 33/350 | 699/18862 | 0 | 1e-04 | 33 |
GO:0035567 | non-canonical Wnt signaling pathway | 14/350 | 153/18862 | 0 | 1e-04 | 14 |
GO:1901361 | organic cyclic compound catabolic process | 31/350 | 637/18862 | 0 | 1e-04 | 31 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 15/350 | 177/18862 | 0 | 1e-04 | 15 |
GO:2000736 | regulation of stem cell differentiation | 12/350 | 112/18862 | 0 | 1e-04 | 12 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 11/350 | 93/18862 | 0 | 1e-04 | 11 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 10/350 | 75/18862 | 0 | 1e-04 | 10 |
GO:0050852 | T cell receptor signaling pathway | 16/350 | 204/18862 | 0 | 1e-04 | 16 |
GO:1902600 | proton transmembrane transport | 14/350 | 157/18862 | 0 | 1e-04 | 14 |
GO:0000209 | protein polyubiquitination | 21/350 | 337/18862 | 0 | 1e-04 | 21 |
GO:0071453 | cellular response to oxygen levels | 17/350 | 231/18862 | 0 | 1e-04 | 17 |
GO:0071456 | cellular response to hypoxia | 16/350 | 206/18862 | 0 | 1e-04 | 16 |
GO:0034655 | nucleobase-containing compound catabolic process | 28/350 | 553/18862 | 0 | 1e-04 | 28 |
GO:0046700 | heterocycle catabolic process | 29/350 | 587/18862 | 0 | 1e-04 | 29 |
GO:0019882 | antigen processing and presentation | 17/350 | 234/18862 | 0 | 1e-04 | 17 |
GO:0050684 | regulation of mRNA processing | 13/350 | 139/18862 | 0 | 1e-04 | 13 |
GO:0006402 | mRNA catabolic process | 22/350 | 375/18862 | 0 | 1e-04 | 22 |
GO:0006446 | regulation of translational initiation | 10/350 | 80/18862 | 0 | 1e-04 | 10 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 10/350 | 80/18862 | 0 | 1e-04 | 10 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 11/350 | 99/18862 | 0 | 1e-04 | 11 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 11/350 | 99/18862 | 0 | 1e-04 | 11 |
GO:0042773 | ATP synthesis coupled electron transport | 11/350 | 100/18862 | 0 | 1e-04 | 11 |
GO:0036294 | cellular response to decreased oxygen levels | 16/350 | 214/18862 | 0 | 1e-04 | 16 |
GO:0043484 | regulation of RNA splicing | 13/350 | 145/18862 | 0 | 2e-04 | 13 |
GO:1903793 | positive regulation of anion transport | 25/350 | 478/18862 | 0 | 2e-04 | 25 |
GO:0006520 | cellular amino acid metabolic process | 20/350 | 331/18862 | 0 | 2e-04 | 20 |
GO:0009060 | aerobic respiration | 10/350 | 86/18862 | 0 | 2e-04 | 10 |
GO:2000027 | regulation of animal organ morphogenesis | 14/350 | 176/18862 | 0 | 3e-04 | 14 |
GO:0044270 | cellular nitrogen compound catabolic process | 28/350 | 592/18862 | 0 | 3e-04 | 28 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 11/350 | 111/18862 | 0 | 3e-04 | 11 |
GO:0071347 | cellular response to interleukin-1 | 14/350 | 180/18862 | 0 | 3e-04 | 14 |
GO:0044106 | cellular amine metabolic process | 13/350 | 158/18862 | 0 | 4e-04 | 13 |
GO:0002223 | stimulatory C-type lectin receptor signaling pathway | 11/350 | 114/18862 | 0 | 4e-04 | 11 |
GO:0022613 | ribonucleoprotein complex biogenesis | 24/350 | 473/18862 | 0 | 4e-04 | 24 |
GO:0038061 | NIK/NF-kappaB signaling | 14/350 | 185/18862 | 0 | 5e-04 | 14 |
GO:0009408 | response to heat | 13/350 | 161/18862 | 0 | 5e-04 | 13 |
GO:0006635 | fatty acid beta-oxidation | 9/350 | 75/18862 | 0 | 5e-04 | 9 |
GO:0019439 | aromatic compound catabolic process | 28/350 | 609/18862 | 0 | 5e-04 | 28 |
GO:0009308 | amine metabolic process | 13/350 | 163/18862 | 0 | 5e-04 | 13 |
GO:0051170 | import into nucleus | 13/350 | 163/18862 | 0 | 5e-04 | 13 |
GO:0070482 | response to oxygen levels | 21/350 | 385/18862 | 0 | 5e-04 | 21 |
GO:0072594 | establishment of protein localization to organelle | 27/350 | 579/18862 | 0 | 5e-04 | 27 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 24/350 | 481/18862 | 0 | 5e-04 | 24 |
GO:0002757 | immune response-activating signal transduction | 24/350 | 481/18862 | 0 | 5e-04 | 24 |
GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 11/350 | 118/18862 | 0 | 5e-04 | 11 |
GO:0002758 | innate immune response-activating signal transduction | 11/350 | 119/18862 | 0 | 6e-04 | 11 |
GO:0034605 | cellular response to heat | 11/350 | 120/18862 | 0 | 6e-04 | 11 |
GO:0043687 | post-translational protein modification | 20/350 | 361/18862 | 0 | 6e-04 | 20 |
GO:0017038 | protein import | 14/350 | 194/18862 | 0 | 7e-04 | 14 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 10/350 | 100/18862 | 0 | 7e-04 | 10 |
GO:0044839 | cell cycle G2/M phase transition | 17/350 | 276/18862 | 0 | 7e-04 | 17 |
GO:0009743 | response to carbohydrate | 15/350 | 221/18862 | 0 | 7e-04 | 15 |
GO:2001020 | regulation of response to DNA damage stimulus | 15/350 | 221/18862 | 0 | 7e-04 | 15 |
GO:0034248 | regulation of cellular amide metabolic process | 24/350 | 494/18862 | 0 | 7e-04 | 24 |
GO:0044772 | mitotic cell cycle phase transition | 27/350 | 595/18862 | 0 | 7e-04 | 27 |
GO:0070498 | interleukin-1-mediated signaling pathway | 10/350 | 103/18862 | 0 | 8e-04 | 10 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 13/350 | 174/18862 | 0 | 9e-04 | 13 |
GO:0019395 | fatty acid oxidation | 10/350 | 105/18862 | 0 | 1e-03 | 10 |
GO:0006607 | NLS-bearing protein import into nucleus | 5/350 | 20/18862 | 0 | 1e-03 | 5 |
GO:0045088 | regulation of innate immune response | 18/350 | 315/18862 | 0 | 1e-03 | 18 |
GO:0044770 | cell cycle phase transition | 28/350 | 641/18862 | 0 | 1e-03 | 28 |
GO:0002253 | activation of immune response | 26/350 | 572/18862 | 0 | 1e-03 | 26 |
GO:0000086 | G2/M transition of mitotic cell cycle | 16/350 | 258/18862 | 0 | 1e-03 | 16 |
ID | Description | GeneRatio | BgRatio | pvalue | p.adjust | Count |
---|---|---|---|---|---|---|
GO:0006259 | DNA metabolic process | 85/412 | 954/18862 | 0e+00 | 0e+00 | 85 |
GO:1903311 | regulation of mRNA metabolic process | 48/412 | 334/18862 | 0e+00 | 0e+00 | 48 |
GO:0016071 | mRNA metabolic process | 76/412 | 882/18862 | 0e+00 | 0e+00 | 76 |
GO:1903047 | mitotic cell cycle process | 74/412 | 886/18862 | 0e+00 | 0e+00 | 74 |
GO:0016032 | viral process | 76/412 | 942/18862 | 0e+00 | 0e+00 | 76 |
GO:0044772 | mitotic cell cycle phase transition | 60/412 | 595/18862 | 0e+00 | 0e+00 | 60 |
GO:0010948 | negative regulation of cell cycle process | 47/412 | 359/18862 | 0e+00 | 0e+00 | 47 |
GO:0044403 | biological process involved in symbiotic interaction | 77/412 | 1000/18862 | 0e+00 | 0e+00 | 77 |
GO:0044770 | cell cycle phase transition | 61/412 | 641/18862 | 0e+00 | 0e+00 | 61 |
GO:0006974 | cellular response to DNA damage stimulus | 67/412 | 869/18862 | 0e+00 | 0e+00 | 67 |
GO:0010564 | regulation of cell cycle process | 63/412 | 789/18862 | 0e+00 | 0e+00 | 63 |
GO:0045786 | negative regulation of cell cycle | 54/412 | 624/18862 | 0e+00 | 0e+00 | 54 |
GO:0007346 | regulation of mitotic cell cycle | 53/412 | 605/18862 | 0e+00 | 0e+00 | 53 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 45/412 | 439/18862 | 0e+00 | 0e+00 | 45 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 42/412 | 383/18862 | 0e+00 | 0e+00 | 42 |
GO:0000398 | mRNA splicing, via spliceosome | 42/412 | 383/18862 | 0e+00 | 0e+00 | 42 |
GO:0006397 | mRNA processing | 50/412 | 546/18862 | 0e+00 | 0e+00 | 50 |
GO:0000375 | RNA splicing, via transesterification reactions | 42/412 | 386/18862 | 0e+00 | 0e+00 | 42 |
GO:0006281 | DNA repair | 51/412 | 569/18862 | 0e+00 | 0e+00 | 51 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 34/412 | 250/18862 | 0e+00 | 0e+00 | 34 |
GO:0006403 | RNA localization | 33/412 | 234/18862 | 0e+00 | 0e+00 | 33 |
GO:1901987 | regulation of cell cycle phase transition | 46/412 | 478/18862 | 0e+00 | 0e+00 | 46 |
GO:0033044 | regulation of chromosome organization | 35/412 | 273/18862 | 0e+00 | 0e+00 | 35 |
GO:1901988 | negative regulation of cell cycle phase transition | 34/412 | 268/18862 | 0e+00 | 0e+00 | 34 |
GO:0008380 | RNA splicing | 45/412 | 481/18862 | 0e+00 | 0e+00 | 45 |
GO:0050684 | regulation of mRNA processing | 25/412 | 139/18862 | 0e+00 | 0e+00 | 25 |
GO:0006260 | DNA replication | 33/412 | 280/18862 | 0e+00 | 0e+00 | 33 |
GO:0060218 | hematopoietic stem cell differentiation | 20/412 | 88/18862 | 0e+00 | 0e+00 | 20 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 29/412 | 219/18862 | 0e+00 | 0e+00 | 29 |
GO:0000082 | G1/S transition of mitotic cell cycle | 32/412 | 275/18862 | 0e+00 | 0e+00 | 32 |
GO:0000723 | telomere maintenance | 25/412 | 161/18862 | 0e+00 | 0e+00 | 25 |
GO:0006325 | chromatin organization | 56/412 | 807/18862 | 0e+00 | 0e+00 | 56 |
GO:2001252 | positive regulation of chromosome organization | 25/412 | 164/18862 | 0e+00 | 0e+00 | 25 |
GO:1902036 | regulation of hematopoietic stem cell differentiation | 18/412 | 74/18862 | 0e+00 | 0e+00 | 18 |
GO:0071824 | protein-DNA complex subunit organization | 32/412 | 281/18862 | 0e+00 | 0e+00 | 32 |
GO:0045930 | negative regulation of mitotic cell cycle | 34/412 | 321/18862 | 0e+00 | 0e+00 | 34 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 27/412 | 203/18862 | 0e+00 | 0e+00 | 27 |
GO:0032200 | telomere organization | 25/412 | 174/18862 | 0e+00 | 0e+00 | 25 |
GO:0044843 | cell cycle G1/S phase transition | 32/412 | 298/18862 | 0e+00 | 0e+00 | 32 |
GO:0002244 | hematopoietic progenitor cell differentiation | 24/412 | 161/18862 | 0e+00 | 0e+00 | 24 |
GO:0002520 | immune system development | 61/412 | 989/18862 | 0e+00 | 0e+00 | 61 |
GO:2000736 | regulation of stem cell differentiation | 20/412 | 112/18862 | 0e+00 | 0e+00 | 20 |
GO:0071103 | DNA conformation change | 34/412 | 352/18862 | 0e+00 | 0e+00 | 34 |
GO:0051052 | regulation of DNA metabolic process | 34/412 | 353/18862 | 0e+00 | 0e+00 | 34 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 19/412 | 100/18862 | 0e+00 | 0e+00 | 19 |
GO:0044839 | cell cycle G2/M phase transition | 30/412 | 276/18862 | 0e+00 | 0e+00 | 30 |
GO:0043488 | regulation of mRNA stability | 25/412 | 188/18862 | 0e+00 | 0e+00 | 25 |
GO:0032392 | DNA geometric change | 20/412 | 114/18862 | 0e+00 | 0e+00 | 20 |
GO:0065004 | protein-DNA complex assembly | 28/412 | 241/18862 | 0e+00 | 0e+00 | 28 |
GO:0070198 | protein localization to chromosome, telomeric region | 12/412 | 30/18862 | 0e+00 | 0e+00 | 12 |
GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 18/412 | 89/18862 | 0e+00 | 0e+00 | 18 |
GO:0061013 | regulation of mRNA catabolic process | 26/412 | 210/18862 | 0e+00 | 0e+00 | 26 |
GO:0030097 | hemopoiesis | 56/412 | 892/18862 | 0e+00 | 0e+00 | 56 |
GO:0032204 | regulation of telomere maintenance | 17/412 | 79/18862 | 0e+00 | 0e+00 | 17 |
GO:0071897 | DNA biosynthetic process | 25/412 | 194/18862 | 0e+00 | 0e+00 | 25 |
GO:0002218 | activation of innate immune response | 22/412 | 148/18862 | 0e+00 | 0e+00 | 22 |
GO:0043487 | regulation of RNA stability | 25/412 | 198/18862 | 0e+00 | 0e+00 | 25 |
GO:0051054 | positive regulation of DNA metabolic process | 25/412 | 198/18862 | 0e+00 | 0e+00 | 25 |
GO:2000278 | regulation of DNA biosynthetic process | 19/412 | 107/18862 | 0e+00 | 0e+00 | 19 |
GO:1904356 | regulation of telomere maintenance via telomere lengthening | 15/412 | 60/18862 | 0e+00 | 0e+00 | 15 |
GO:1904851 | positive regulation of establishment of protein localization to telomere | 8/412 | 10/18862 | 0e+00 | 0e+00 | 8 |
GO:0034655 | nucleobase-containing compound catabolic process | 42/412 | 553/18862 | 0e+00 | 0e+00 | 42 |
GO:0032206 | positive regulation of telomere maintenance | 14/412 | 51/18862 | 0e+00 | 0e+00 | 14 |
GO:0000086 | G2/M transition of mitotic cell cycle | 28/412 | 258/18862 | 0e+00 | 0e+00 | 28 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 18/412 | 100/18862 | 0e+00 | 0e+00 | 18 |
GO:0048534 | hematopoietic or lymphoid organ development | 56/412 | 932/18862 | 0e+00 | 0e+00 | 56 |
GO:0043484 | regulation of RNA splicing | 21/412 | 145/18862 | 0e+00 | 0e+00 | 21 |
GO:2000573 | positive regulation of DNA biosynthetic process | 15/412 | 65/18862 | 0e+00 | 0e+00 | 15 |
GO:0070203 | regulation of establishment of protein localization to telomere | 8/412 | 11/18862 | 0e+00 | 0e+00 | 8 |
GO:1904869 | regulation of protein localization to Cajal body | 8/412 | 11/18862 | 0e+00 | 0e+00 | 8 |
GO:1904871 | positive regulation of protein localization to Cajal body | 8/412 | 11/18862 | 0e+00 | 0e+00 | 8 |
GO:1904358 | positive regulation of telomere maintenance via telomere lengthening | 12/412 | 36/18862 | 0e+00 | 0e+00 | 12 |
GO:0071826 | ribonucleoprotein complex subunit organization | 26/412 | 231/18862 | 0e+00 | 0e+00 | 26 |
GO:0034502 | protein localization to chromosome | 17/412 | 91/18862 | 0e+00 | 0e+00 | 17 |
GO:0046700 | heterocycle catabolic process | 42/412 | 587/18862 | 0e+00 | 0e+00 | 42 |
GO:0010833 | telomere maintenance via telomere lengthening | 16/412 | 80/18862 | 0e+00 | 0e+00 | 16 |
GO:0002833 | positive regulation of response to biotic stimulus | 27/412 | 258/18862 | 0e+00 | 0e+00 | 27 |
GO:0044270 | cellular nitrogen compound catabolic process | 42/412 | 592/18862 | 0e+00 | 0e+00 | 42 |
GO:0006310 | DNA recombination | 29/412 | 299/18862 | 0e+00 | 0e+00 | 29 |
GO:0070202 | regulation of establishment of protein localization to chromosome | 8/412 | 12/18862 | 0e+00 | 0e+00 | 8 |
GO:1903405 | protein localization to nuclear body | 8/412 | 12/18862 | 0e+00 | 0e+00 | 8 |
GO:1904816 | positive regulation of protein localization to chromosome, telomeric region | 8/412 | 12/18862 | 0e+00 | 0e+00 | 8 |
GO:1904867 | protein localization to Cajal body | 8/412 | 12/18862 | 0e+00 | 0e+00 | 8 |
GO:0045089 | positive regulation of innate immune response | 25/412 | 223/18862 | 0e+00 | 0e+00 | 25 |
GO:0022618 | ribonucleoprotein complex assembly | 25/412 | 224/18862 | 0e+00 | 0e+00 | 25 |
GO:0031145 | anaphase-promoting complex-dependent catabolic process | 16/412 | 83/18862 | 0e+00 | 0e+00 | 16 |
GO:1902750 | negative regulation of cell cycle G2/M phase transition | 18/412 | 111/18862 | 0e+00 | 0e+00 | 18 |
GO:0006401 | RNA catabolic process | 34/412 | 414/18862 | 0e+00 | 0e+00 | 34 |
GO:0070200 | establishment of protein localization to telomere | 9/412 | 18/18862 | 0e+00 | 0e+00 | 9 |
GO:0019439 | aromatic compound catabolic process | 42/412 | 609/18862 | 0e+00 | 0e+00 | 42 |
GO:0006521 | regulation of cellular amino acid metabolic process | 14/412 | 62/18862 | 0e+00 | 0e+00 | 14 |
GO:0006402 | mRNA catabolic process | 32/412 | 375/18862 | 0e+00 | 0e+00 | 32 |
GO:0032212 | positive regulation of telomere maintenance via telomerase | 11/412 | 33/18862 | 0e+00 | 0e+00 | 11 |
GO:0032210 | regulation of telomere maintenance via telomerase | 13/412 | 52/18862 | 0e+00 | 0e+00 | 13 |
GO:0006278 | RNA-dependent DNA biosynthetic process | 15/412 | 75/18862 | 0e+00 | 0e+00 | 15 |
GO:0051236 | establishment of RNA localization | 23/412 | 201/18862 | 0e+00 | 0e+00 | 23 |
GO:0033238 | regulation of cellular amine metabolic process | 15/412 | 77/18862 | 0e+00 | 0e+00 | 15 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 15/412 | 77/18862 | 0e+00 | 0e+00 | 15 |
GO:0051169 | nuclear transport | 30/412 | 343/18862 | 0e+00 | 0e+00 | 30 |
GO:1904814 | regulation of protein localization to chromosome, telomeric region | 8/412 | 14/18862 | 0e+00 | 0e+00 | 8 |
GO:1990173 | protein localization to nucleoplasm | 8/412 | 14/18862 | 0e+00 | 0e+00 | 8 |
GO:0007004 | telomere maintenance via telomerase | 14/412 | 68/18862 | 0e+00 | 0e+00 | 14 |
GO:1901361 | organic cyclic compound catabolic process | 42/412 | 637/18862 | 0e+00 | 0e+00 | 42 |
GO:0006261 | DNA-dependent DNA replication | 20/412 | 157/18862 | 0e+00 | 0e+00 | 20 |
GO:0006352 | DNA-templated transcription, initiation | 25/412 | 249/18862 | 0e+00 | 0e+00 | 25 |
GO:1904874 | positive regulation of telomerase RNA localization to Cajal body | 8/412 | 15/18862 | 0e+00 | 0e+00 | 8 |
GO:0022613 | ribonucleoprotein complex biogenesis | 35/412 | 473/18862 | 0e+00 | 0e+00 | 35 |
GO:0050657 | nucleic acid transport | 22/412 | 198/18862 | 0e+00 | 0e+00 | 22 |
GO:0050658 | RNA transport | 22/412 | 198/18862 | 0e+00 | 0e+00 | 22 |
GO:0006913 | nucleocytoplasmic transport | 29/412 | 340/18862 | 0e+00 | 0e+00 | 29 |
GO:0031329 | regulation of cellular catabolic process | 49/412 | 848/18862 | 0e+00 | 0e+00 | 49 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 14/412 | 75/18862 | 0e+00 | 0e+00 | 14 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 21/412 | 187/18862 | 0e+00 | 0e+00 | 21 |
GO:0032508 | DNA duplex unwinding | 16/412 | 107/18862 | 0e+00 | 0e+00 | 16 |
GO:0048863 | stem cell differentiation | 24/412 | 251/18862 | 0e+00 | 0e+00 | 24 |
GO:0045088 | regulation of innate immune response | 27/412 | 315/18862 | 0e+00 | 0e+00 | 27 |
GO:1904872 | regulation of telomerase RNA localization to Cajal body | 8/412 | 18/18862 | 0e+00 | 0e+00 | 8 |
GO:0015931 | nucleobase-containing compound transport | 24/412 | 253/18862 | 0e+00 | 0e+00 | 24 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 14/412 | 80/18862 | 0e+00 | 0e+00 | 14 |
GO:0090670 | RNA localization to Cajal body | 8/412 | 19/18862 | 0e+00 | 0e+00 | 8 |
GO:0090671 | telomerase RNA localization to Cajal body | 8/412 | 19/18862 | 0e+00 | 0e+00 | 8 |
GO:0090672 | telomerase RNA localization | 8/412 | 19/18862 | 0e+00 | 0e+00 | 8 |
GO:0090685 | RNA localization to nucleus | 8/412 | 19/18862 | 0e+00 | 0e+00 | 8 |
GO:0060249 | anatomical structure homeostasis | 33/412 | 466/18862 | 0e+00 | 0e+00 | 33 |
GO:0070199 | establishment of protein localization to chromosome | 9/412 | 27/18862 | 0e+00 | 0e+00 | 9 |
GO:0016579 | protein deubiquitination | 25/412 | 283/18862 | 0e+00 | 0e+00 | 25 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 15/412 | 99/18862 | 0e+00 | 0e+00 | 15 |
GO:0072331 | signal transduction by p53 class mediator | 24/412 | 263/18862 | 0e+00 | 0e+00 | 24 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 48/412 | 873/18862 | 0e+00 | 0e+00 | 48 |
GO:0033260 | nuclear DNA replication | 12/412 | 59/18862 | 0e+00 | 0e+00 | 12 |
GO:0070897 | transcription preinitiation complex assembly | 10/412 | 37/18862 | 0e+00 | 0e+00 | 10 |
GO:0006302 | double-strand break repair | 24/412 | 268/18862 | 0e+00 | 0e+00 | 24 |
GO:0010638 | positive regulation of organelle organization | 37/412 | 583/18862 | 0e+00 | 0e+00 | 37 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 19/412 | 174/18862 | 0e+00 | 0e+00 | 19 |
GO:0044106 | cellular amine metabolic process | 18/412 | 158/18862 | 0e+00 | 0e+00 | 18 |
GO:0070646 | protein modification by small protein removal | 25/412 | 300/18862 | 0e+00 | 0e+00 | 25 |
GO:0044786 | cell cycle DNA replication | 12/412 | 64/18862 | 0e+00 | 0e+00 | 12 |
GO:0050778 | positive regulation of immune response | 43/412 | 760/18862 | 0e+00 | 0e+00 | 43 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 15/412 | 108/18862 | 0e+00 | 0e+00 | 15 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 14/412 | 93/18862 | 0e+00 | 0e+00 | 14 |
GO:0002831 | regulation of response to biotic stimulus | 30/412 | 420/18862 | 0e+00 | 0e+00 | 30 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 15/412 | 109/18862 | 0e+00 | 0e+00 | 15 |
GO:0009308 | amine metabolic process | 18/412 | 163/18862 | 0e+00 | 0e+00 | 18 |
GO:0090175 | regulation of establishment of planar polarity | 15/412 | 112/18862 | 0e+00 | 0e+00 | 15 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 14/412 | 98/18862 | 0e+00 | 0e+00 | 14 |
GO:0031349 | positive regulation of defense response | 27/412 | 361/18862 | 0e+00 | 0e+00 | 27 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 15/412 | 115/18862 | 0e+00 | 0e+00 | 15 |
GO:0071478 | cellular response to radiation | 19/412 | 191/18862 | 0e+00 | 0e+00 | 19 |
GO:0035567 | non-canonical Wnt signaling pathway | 17/412 | 153/18862 | 0e+00 | 0e+00 | 17 |
GO:0002220 | innate immune response activating cell surface receptor signaling pathway | 15/412 | 118/18862 | 0e+00 | 0e+00 | 15 |
GO:0002253 | activation of immune response | 35/412 | 572/18862 | 0e+00 | 0e+00 | 35 |
GO:0002758 | innate immune response-activating signal transduction | 15/412 | 119/18862 | 0e+00 | 0e+00 | 15 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 15/412 | 119/18862 | 0e+00 | 0e+00 | 15 |
GO:0070498 | interleukin-1-mediated signaling pathway | 14/412 | 103/18862 | 0e+00 | 0e+00 | 14 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 12/412 | 73/18862 | 0e+00 | 0e+00 | 12 |
GO:0009314 | response to radiation | 30/412 | 447/18862 | 0e+00 | 0e+00 | 30 |
GO:0002521 | leukocyte differentiation | 33/412 | 525/18862 | 0e+00 | 0e+00 | 33 |
GO:1902806 | regulation of cell cycle G1/S phase transition | 19/412 | 195/18862 | 0e+00 | 0e+00 | 19 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 29/412 | 425/18862 | 0e+00 | 0e+00 | 29 |
GO:0006353 | DNA-templated transcription, termination | 12/412 | 75/18862 | 0e+00 | 0e+00 | 12 |
GO:0000726 | non-recombinational repair | 14/412 | 106/18862 | 0e+00 | 0e+00 | 14 |
GO:0001736 | establishment of planar polarity | 15/412 | 123/18862 | 0e+00 | 0e+00 | 15 |
GO:0007164 | establishment of tissue polarity | 15/412 | 123/18862 | 0e+00 | 0e+00 | 15 |
GO:1902807 | negative regulation of cell cycle G1/S phase transition | 15/412 | 124/18862 | 0e+00 | 0e+00 | 15 |
GO:0010212 | response to ionizing radiation | 16/412 | 142/18862 | 0e+00 | 0e+00 | 16 |
GO:0051168 | nuclear export | 19/412 | 201/18862 | 0e+00 | 0e+00 | 19 |
GO:0006289 | nucleotide-excision repair | 14/412 | 108/18862 | 0e+00 | 0e+00 | 14 |
GO:0001738 | morphogenesis of a polarized epithelium | 16/412 | 144/18862 | 0e+00 | 0e+00 | 16 |
GO:0050852 | T cell receptor signaling pathway | 19/412 | 204/18862 | 0e+00 | 0e+00 | 19 |
GO:1901998 | toxin transport | 9/412 | 39/18862 | 0e+00 | 0e+00 | 9 |
GO:0062012 | regulation of small molecule metabolic process | 29/412 | 437/18862 | 0e+00 | 0e+00 | 29 |
GO:0050686 | negative regulation of mRNA processing | 8/412 | 29/18862 | 0e+00 | 0e+00 | 8 |
GO:0010332 | response to gamma radiation | 10/412 | 53/18862 | 0e+00 | 0e+00 | 10 |
GO:0002223 | stimulatory C-type lectin receptor signaling pathway | 14/412 | 114/18862 | 0e+00 | 0e+00 | 14 |
GO:0042180 | cellular ketone metabolic process | 21/412 | 254/18862 | 0e+00 | 0e+00 | 21 |
GO:1904951 | positive regulation of establishment of protein localization | 24/412 | 328/18862 | 0e+00 | 0e+00 | 24 |
GO:0071214 | cellular response to abiotic stimulus | 24/412 | 330/18862 | 0e+00 | 0e+00 | 24 |
GO:0104004 | cellular response to environmental stimulus | 24/412 | 330/18862 | 0e+00 | 0e+00 | 24 |
GO:0010498 | proteasomal protein catabolic process | 30/412 | 483/18862 | 0e+00 | 0e+00 | 30 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 17/412 | 177/18862 | 0e+00 | 0e+00 | 17 |
GO:1901796 | regulation of signal transduction by p53 class mediator | 17/412 | 177/18862 | 0e+00 | 0e+00 | 17 |
GO:0070482 | response to oxygen levels | 26/412 | 385/18862 | 0e+00 | 0e+00 | 26 |
GO:0006412 | translation | 38/412 | 716/18862 | 0e+00 | 0e+00 | 38 |
GO:0070201 | regulation of establishment of protein localization | 33/412 | 574/18862 | 0e+00 | 0e+00 | 33 |
GO:1903312 | negative regulation of mRNA metabolic process | 12/412 | 88/18862 | 0e+00 | 0e+00 | 12 |
GO:0006405 | RNA export from nucleus | 15/412 | 142/18862 | 0e+00 | 0e+00 | 15 |
GO:0006091 | generation of precursor metabolites and energy | 31/412 | 524/18862 | 0e+00 | 0e+00 | 31 |
GO:0008334 | histone mRNA metabolic process | 7/412 | 24/18862 | 0e+00 | 0e+00 | 7 |
GO:0006518 | peptide metabolic process | 44/412 | 905/18862 | 0e+00 | 0e+00 | 44 |
GO:0048524 | positive regulation of viral process | 12/412 | 91/18862 | 0e+00 | 0e+00 | 12 |
GO:0071456 | cellular response to hypoxia | 18/412 | 206/18862 | 0e+00 | 0e+00 | 18 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 17/412 | 185/18862 | 0e+00 | 0e+00 | 17 |
GO:0016570 | histone modification | 28/412 | 448/18862 | 0e+00 | 0e+00 | 28 |
GO:0050792 | regulation of viral process | 17/412 | 186/18862 | 0e+00 | 0e+00 | 17 |
GO:0051123 | RNA polymerase II preinitiation complex assembly | 7/412 | 25/18862 | 0e+00 | 0e+00 | 7 |
GO:0001666 | response to hypoxia | 24/412 | 348/18862 | 0e+00 | 0e+00 | 24 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 15/412 | 147/18862 | 0e+00 | 0e+00 | 15 |
GO:0071453 | cellular response to oxygen levels | 19/412 | 231/18862 | 0e+00 | 0e+00 | 19 |
GO:0032481 | positive regulation of type I interferon production | 11/412 | 77/18862 | 0e+00 | 0e+00 | 11 |
GO:0032103 | positive regulation of response to external stimulus | 30/412 | 509/18862 | 0e+00 | 0e+00 | 30 |
GO:0016571 | histone methylation | 14/412 | 130/18862 | 0e+00 | 0e+00 | 14 |
GO:0006479 | protein methylation | 16/412 | 170/18862 | 0e+00 | 0e+00 | 16 |
GO:0008213 | protein alkylation | 16/412 | 170/18862 | 0e+00 | 0e+00 | 16 |
GO:0043043 | peptide biosynthetic process | 38/412 | 742/18862 | 0e+00 | 0e+00 | 38 |
GO:0006520 | cellular amino acid metabolic process | 23/412 | 331/18862 | 0e+00 | 0e+00 | 23 |
GO:0036294 | cellular response to decreased oxygen levels | 18/412 | 214/18862 | 0e+00 | 0e+00 | 18 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 10/412 | 64/18862 | 0e+00 | 0e+00 | 10 |
GO:0016444 | somatic cell DNA recombination | 10/412 | 64/18862 | 0e+00 | 0e+00 | 10 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 30/412 | 515/18862 | 0e+00 | 0e+00 | 30 |
GO:0016569 | covalent chromatin modification | 28/412 | 461/18862 | 0e+00 | 0e+00 | 28 |
GO:0051301 | cell division | 33/412 | 600/18862 | 0e+00 | 0e+00 | 33 |
GO:0000245 | spliceosomal complex assembly | 11/412 | 80/18862 | 0e+00 | 0e+00 | 11 |
GO:0048002 | antigen processing and presentation of peptide antigen | 17/412 | 194/18862 | 0e+00 | 0e+00 | 17 |
GO:0002764 | immune response-regulating signaling pathway | 30/412 | 518/18862 | 0e+00 | 0e+00 | 30 |
GO:0036293 | response to decreased oxygen levels | 24/412 | 360/18862 | 0e+00 | 0e+00 | 24 |
GO:1903827 | regulation of cellular protein localization | 31/412 | 548/18862 | 0e+00 | 0e+00 | 31 |
GO:0006323 | DNA packaging | 19/412 | 240/18862 | 0e+00 | 0e+00 | 19 |
GO:0060341 | regulation of cellular localization | 40/412 | 813/18862 | 0e+00 | 0e+00 | 40 |
GO:0032880 | regulation of protein localization | 42/412 | 875/18862 | 0e+00 | 0e+00 | 42 |
GO:0043903 | regulation of biological process involved in symbiotic interaction | 17/412 | 197/18862 | 0e+00 | 0e+00 | 17 |
GO:2000027 | regulation of animal organ morphogenesis | 16/412 | 176/18862 | 0e+00 | 0e+00 | 16 |
GO:0019042 | viral latency | 5/412 | 11/18862 | 0e+00 | 0e+00 | 5 |
GO:0006270 | DNA replication initiation | 8/412 | 40/18862 | 0e+00 | 0e+00 | 8 |
GO:0006354 | DNA-templated transcription, elongation | 13/412 | 119/18862 | 0e+00 | 0e+00 | 13 |
GO:0030177 | positive regulation of Wnt signaling pathway | 16/412 | 179/18862 | 0e+00 | 0e+00 | 16 |
GO:1903829 | positive regulation of cellular protein localization | 21/412 | 295/18862 | 0e+00 | 0e+00 | 21 |
GO:0070317 | negative regulation of G0 to G1 transition | 8/412 | 41/18862 | 0e+00 | 0e+00 | 8 |
GO:0061136 | regulation of proteasomal protein catabolic process | 16/412 | 182/18862 | 0e+00 | 1e-04 | 16 |
GO:0031056 | regulation of histone modification | 14/412 | 141/18862 | 0e+00 | 1e-04 | 14 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 28/412 | 481/18862 | 0e+00 | 1e-04 | 28 |
GO:0002757 | immune response-activating signal transduction | 28/412 | 481/18862 | 0e+00 | 1e-04 | 28 |
GO:0050851 | antigen receptor-mediated signaling pathway | 22/412 | 323/18862 | 0e+00 | 1e-04 | 22 |
GO:0006611 | protein export from nucleus | 16/412 | 183/18862 | 0e+00 | 1e-04 | 16 |
GO:1903362 | regulation of cellular protein catabolic process | 19/412 | 251/18862 | 0e+00 | 1e-04 | 19 |
GO:0070555 | response to interleukin-1 | 17/412 | 206/18862 | 0e+00 | 1e-04 | 17 |
GO:0043632 | modification-dependent macromolecule catabolic process | 34/412 | 656/18862 | 0e+00 | 1e-04 | 34 |
GO:0010565 | regulation of cellular ketone metabolic process | 16/412 | 185/18862 | 0e+00 | 1e-04 | 16 |
GO:0038061 | NIK/NF-kappaB signaling | 16/412 | 185/18862 | 0e+00 | 1e-04 | 16 |
GO:0051095 | regulation of helicase activity | 5/412 | 12/18862 | 0e+00 | 1e-04 | 5 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 9/412 | 57/18862 | 0e+00 | 1e-04 | 9 |
GO:0006457 | protein folding | 18/412 | 233/18862 | 0e+00 | 1e-04 | 18 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 10/412 | 73/18862 | 0e+00 | 1e-04 | 10 |
GO:0019882 | antigen processing and presentation | 18/412 | 234/18862 | 0e+00 | 1e-04 | 18 |
GO:1903131 | mononuclear cell differentiation | 25/412 | 411/18862 | 0e+00 | 1e-04 | 25 |
GO:0031503 | protein-containing complex localization | 20/412 | 283/18862 | 0e+00 | 1e-04 | 20 |
GO:2001251 | negative regulation of chromosome organization | 11/412 | 91/18862 | 0e+00 | 1e-04 | 11 |
GO:0098781 | ncRNA transcription | 12/412 | 109/18862 | 0e+00 | 1e-04 | 12 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 15/412 | 169/18862 | 0e+00 | 1e-04 | 15 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 33/412 | 639/18862 | 0e+00 | 1e-04 | 33 |
GO:0050821 | protein stabilization | 16/412 | 191/18862 | 0e+00 | 1e-04 | 16 |
GO:0043687 | post-translational protein modification | 23/412 | 361/18862 | 0e+00 | 1e-04 | 23 |
GO:0006418 | tRNA aminoacylation for protein translation | 8/412 | 45/18862 | 0e+00 | 1e-04 | 8 |
GO:0002200 | somatic diversification of immune receptors | 10/412 | 75/18862 | 0e+00 | 1e-04 | 10 |
GO:0030162 | regulation of proteolysis | 36/412 | 733/18862 | 0e+00 | 1e-04 | 36 |
GO:0000209 | protein polyubiquitination | 22/412 | 337/18862 | 0e+00 | 1e-04 | 22 |
GO:0038093 | Fc receptor signaling pathway | 18/412 | 239/18862 | 0e+00 | 1e-04 | 18 |
GO:0019941 | modification-dependent protein catabolic process | 33/412 | 645/18862 | 0e+00 | 1e-04 | 33 |
GO:0010499 | proteasomal ubiquitin-independent protein catabolic process | 6/412 | 22/18862 | 0e+00 | 1e-04 | 6 |
GO:0032069 | regulation of nuclease activity | 6/412 | 22/18862 | 0e+00 | 1e-04 | 6 |
GO:0044257 | cellular protein catabolic process | 38/412 | 797/18862 | 0e+00 | 1e-04 | 38 |
GO:0018205 | peptidyl-lysine modification | 24/412 | 391/18862 | 0e+00 | 1e-04 | 24 |
GO:0070316 | regulation of G0 to G1 transition | 8/412 | 46/18862 | 0e+00 | 1e-04 | 8 |
GO:0032446 | protein modification by small protein conjugation | 43/412 | 958/18862 | 0e+00 | 1e-04 | 43 |
GO:0051028 | mRNA transport | 14/412 | 152/18862 | 0e+00 | 1e-04 | 14 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 15/412 | 174/18862 | 0e+00 | 1e-04 | 15 |
GO:0045787 | positive regulation of cell cycle | 24/412 | 395/18862 | 0e+00 | 1e-04 | 24 |
GO:0019221 | cytokine-mediated signaling pathway | 38/412 | 804/18862 | 0e+00 | 1e-04 | 38 |
GO:0045023 | G0 to G1 transition | 8/412 | 47/18862 | 0e+00 | 1e-04 | 8 |
GO:0051972 | regulation of telomerase activity | 8/412 | 47/18862 | 0e+00 | 1e-04 | 8 |
GO:1902107 | positive regulation of leukocyte differentiation | 14/412 | 154/18862 | 0e+00 | 1e-04 | 14 |
GO:1903708 | positive regulation of hemopoiesis | 14/412 | 154/18862 | 0e+00 | 1e-04 | 14 |
GO:0071482 | cellular response to light stimulus | 13/412 | 134/18862 | 0e+00 | 1e-04 | 13 |
GO:2001020 | regulation of response to DNA damage stimulus | 17/412 | 221/18862 | 0e+00 | 1e-04 | 17 |
GO:0045898 | regulation of RNA polymerase II transcription preinitiation complex assembly | 5/412 | 14/18862 | 0e+00 | 1e-04 | 5 |
GO:0043039 | tRNA aminoacylation | 8/412 | 48/18862 | 0e+00 | 1e-04 | 8 |
GO:0060260 | regulation of transcription initiation from RNA polymerase II promoter | 7/412 | 35/18862 | 0e+00 | 1e-04 | 7 |
GO:0045597 | positive regulation of cell differentiation | 39/412 | 845/18862 | 0e+00 | 1e-04 | 39 |
GO:0046649 | lymphocyte activation | 36/412 | 752/18862 | 0e+00 | 2e-04 | 36 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 15/412 | 179/18862 | 0e+00 | 2e-04 | 15 |
GO:0043604 | amide biosynthetic process | 40/412 | 879/18862 | 0e+00 | 2e-04 | 40 |
GO:0043038 | amino acid activation | 8/412 | 49/18862 | 0e+00 | 2e-04 | 8 |
GO:0071347 | cellular response to interleukin-1 | 15/412 | 180/18862 | 0e+00 | 2e-04 | 15 |
GO:0000165 | MAPK cascade | 41/412 | 913/18862 | 0e+00 | 2e-04 | 41 |
GO:0040029 | regulation of gene expression, epigenetic | 16/412 | 205/18862 | 0e+00 | 2e-04 | 16 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 5/412 | 15/18862 | 0e+00 | 2e-04 | 5 |
GO:0072594 | establishment of protein localization to organelle | 30/412 | 579/18862 | 0e+00 | 2e-04 | 30 |
GO:0015980 | energy derivation by oxidation of organic compounds | 19/412 | 278/18862 | 0e+00 | 2e-04 | 19 |
GO:0006304 | DNA modification | 12/412 | 121/18862 | 0e+00 | 2e-04 | 12 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 35/412 | 735/18862 | 0e+00 | 2e-04 | 35 |
GO:1902275 | regulation of chromatin organization | 15/412 | 185/18862 | 0e+00 | 2e-04 | 15 |
GO:0030098 | lymphocyte differentiation | 22/412 | 358/18862 | 0e+00 | 2e-04 | 22 |
GO:0051170 | import into nucleus | 14/412 | 163/18862 | 0e+00 | 2e-04 | 14 |
GO:0032922 | circadian regulation of gene expression | 9/412 | 67/18862 | 0e+00 | 2e-04 | 9 |
GO:0006338 | chromatin remodeling | 16/412 | 209/18862 | 0e+00 | 2e-04 | 16 |
GO:0097193 | intrinsic apoptotic signaling pathway | 19/412 | 283/18862 | 0e+00 | 2e-04 | 19 |
GO:0033151 | V(D)J recombination | 5/412 | 16/18862 | 0e+00 | 3e-04 | 5 |
GO:1902969 | mitotic DNA replication | 5/412 | 16/18862 | 0e+00 | 3e-04 | 5 |
GO:0009060 | aerobic respiration | 10/412 | 86/18862 | 0e+00 | 3e-04 | 10 |
GO:0007059 | chromosome segregation | 21/412 | 337/18862 | 0e+00 | 3e-04 | 21 |
GO:0030099 | myeloid cell differentiation | 24/412 | 419/18862 | 0e+00 | 3e-04 | 24 |
GO:0009411 | response to UV | 13/412 | 146/18862 | 0e+00 | 3e-04 | 13 |
GO:0014070 | response to organic cyclic compound | 40/412 | 907/18862 | 0e+00 | 3e-04 | 40 |
GO:0045862 | positive regulation of proteolysis | 22/412 | 367/18862 | 0e+00 | 3e-04 | 22 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 8/412 | 54/18862 | 0e+00 | 3e-04 | 8 |
GO:0007064 | mitotic sister chromatid cohesion | 6/412 | 27/18862 | 0e+00 | 3e-04 | 6 |
GO:1903050 | regulation of proteolysis involved in cellular protein catabolic process | 16/412 | 215/18862 | 0e+00 | 3e-04 | 16 |
GO:0006275 | regulation of DNA replication | 11/412 | 107/18862 | 0e+00 | 3e-04 | 11 |
GO:0034968 | histone lysine methylation | 11/412 | 107/18862 | 0e+00 | 3e-04 | 11 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 11/412 | 107/18862 | 0e+00 | 3e-04 | 11 |
GO:0009262 | deoxyribonucleotide metabolic process | 7/412 | 40/18862 | 0e+00 | 3e-04 | 7 |
GO:0032479 | regulation of type I interferon production | 12/412 | 128/18862 | 0e+00 | 3e-04 | 12 |
GO:0031347 | regulation of defense response | 33/412 | 694/18862 | 0e+00 | 4e-04 | 33 |
GO:0032606 | type I interferon production | 12/412 | 129/18862 | 0e+00 | 4e-04 | 12 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 10/412 | 90/18862 | 0e+00 | 4e-04 | 10 |
GO:0031497 | chromatin assembly | 15/412 | 196/18862 | 0e+00 | 4e-04 | 15 |
GO:0071426 | ribonucleoprotein complex export from nucleus | 12/412 | 130/18862 | 0e+00 | 4e-04 | 12 |
GO:0031647 | regulation of protein stability | 19/412 | 295/18862 | 0e+00 | 4e-04 | 19 |
GO:0080135 | regulation of cellular response to stress | 33/412 | 699/18862 | 0e+00 | 4e-04 | 33 |
GO:0006333 | chromatin assembly or disassembly | 16/412 | 221/18862 | 0e+00 | 4e-04 | 16 |
GO:0071166 | ribonucleoprotein complex localization | 12/412 | 131/18862 | 0e+00 | 4e-04 | 12 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 6/412 | 29/18862 | 0e+00 | 4e-04 | 6 |
GO:0000819 | sister chromatid segregation | 15/412 | 199/18862 | 0e+00 | 5e-04 | 15 |
GO:0000280 | nuclear division | 24/412 | 436/18862 | 0e+00 | 5e-04 | 24 |
GO:0034248 | regulation of cellular amide metabolic process | 26/412 | 494/18862 | 0e+00 | 5e-04 | 26 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 7/412 | 43/18862 | 0e+00 | 5e-04 | 7 |
GO:2000142 | regulation of DNA-templated transcription, initiation | 7/412 | 43/18862 | 0e+00 | 5e-04 | 7 |
GO:0034504 | protein localization to nucleus | 18/412 | 275/18862 | 0e+00 | 5e-04 | 18 |
GO:0051321 | meiotic cell cycle | 17/412 | 250/18862 | 0e+00 | 5e-04 | 17 |
GO:0022900 | electron transport chain | 14/412 | 178/18862 | 0e+00 | 5e-04 | 14 |
GO:0048545 | response to steroid hormone | 20/412 | 330/18862 | 0e+00 | 6e-04 | 20 |
GO:0007339 | binding of sperm to zona pellucida | 7/412 | 44/18862 | 0e+00 | 6e-04 | 7 |
GO:0006271 | DNA strand elongation involved in DNA replication | 5/412 | 19/18862 | 0e+00 | 6e-04 | 5 |
GO:0016567 | protein ubiquitination | 38/412 | 874/18862 | 0e+00 | 6e-04 | 38 |
GO:0009725 | response to hormone | 38/412 | 876/18862 | 0e+00 | 6e-04 | 38 |
GO:0045070 | positive regulation of viral genome replication | 6/412 | 31/18862 | 0e+00 | 6e-04 | 6 |
GO:0051402 | neuron apoptotic process | 16/412 | 230/18862 | 0e+00 | 6e-04 | 16 |
GO:0030163 | protein catabolic process | 40/412 | 948/18862 | 1e-04 | 7e-04 | 40 |
GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 5/412 | 20/18862 | 1e-04 | 8e-04 | 5 |
GO:0044728 | DNA methylation or demethylation | 10/412 | 99/18862 | 1e-04 | 8e-04 | 10 |
GO:0045899 | positive regulation of RNA polymerase II transcription preinitiation complex assembly | 4/412 | 11/18862 | 1e-04 | 9e-04 | 4 |
GO:0006417 | regulation of translation | 23/412 | 425/18862 | 1e-04 | 9e-04 | 23 |
GO:0043462 | regulation of ATPase activity | 9/412 | 81/18862 | 1e-04 | 9e-04 | 9 |
GO:0030178 | negative regulation of Wnt signaling pathway | 15/412 | 212/18862 | 1e-04 | 9e-04 | 15 |
GO:0060964 | regulation of gene silencing by miRNA | 11/412 | 121/18862 | 1e-04 | 9e-04 | 11 |
GO:0051973 | positive regulation of telomerase activity | 6/412 | 33/18862 | 1e-04 | 9e-04 | 6 |
GO:0045621 | positive regulation of lymphocyte differentiation | 10/412 | 101/18862 | 1e-04 | 9e-04 | 10 |
GO:0048285 | organelle fission | 25/412 | 486/18862 | 1e-04 | 9e-04 | 25 |
GO:0016445 | somatic diversification of immunoglobulins | 8/412 | 64/18862 | 1e-04 | 9e-04 | 8 |
GO:0009165 | nucleotide biosynthetic process | 17/412 | 264/18862 | 1e-04 | 1e-03 | 17 |
GO:0060968 | regulation of gene silencing | 12/412 | 144/18862 | 1e-04 | 1e-03 | 12 |
ID | Description | GeneRatio | BgRatio | pvalue | p.adjust | Count |
---|---|---|---|---|---|---|
GO:0045055 | regulated exocytosis | 47/202 | 779/18862 | 0 | 0e+00 | 47 |
GO:0002366 | leukocyte activation involved in immune response | 45/202 | 718/18862 | 0 | 0e+00 | 45 |
GO:0002263 | cell activation involved in immune response | 45/202 | 722/18862 | 0 | 0e+00 | 45 |
GO:0002274 | myeloid leukocyte activation | 43/202 | 659/18862 | 0 | 0e+00 | 43 |
GO:0006887 | exocytosis | 49/202 | 891/18862 | 0 | 0e+00 | 49 |
GO:0043299 | leukocyte degranulation | 39/202 | 535/18862 | 0 | 0e+00 | 39 |
GO:0002444 | myeloid leukocyte mediated immunity | 39/202 | 550/18862 | 0 | 0e+00 | 39 |
GO:0002275 | myeloid cell activation involved in immune response | 38/202 | 548/18862 | 0 | 0e+00 | 38 |
GO:0002443 | leukocyte mediated immunity | 46/202 | 882/18862 | 0 | 0e+00 | 46 |
GO:0042119 | neutrophil activation | 35/202 | 500/18862 | 0 | 0e+00 | 35 |
GO:0036230 | granulocyte activation | 35/202 | 506/18862 | 0 | 0e+00 | 35 |
GO:0043312 | neutrophil degranulation | 33/202 | 485/18862 | 0 | 0e+00 | 33 |
GO:0002283 | neutrophil activation involved in immune response | 33/202 | 488/18862 | 0 | 0e+00 | 33 |
GO:0002446 | neutrophil mediated immunity | 33/202 | 499/18862 | 0 | 0e+00 | 33 |
GO:0002237 | response to molecule of bacterial origin | 24/202 | 346/18862 | 0 | 0e+00 | 24 |
GO:0009617 | response to bacterium | 33/202 | 724/18862 | 0 | 0e+00 | 33 |
GO:0033993 | response to lipid | 36/202 | 865/18862 | 0 | 0e+00 | 36 |
GO:0032496 | response to lipopolysaccharide | 22/202 | 326/18862 | 0 | 0e+00 | 22 |
GO:0006954 | inflammatory response | 31/202 | 775/18862 | 0 | 0e+00 | 31 |
GO:0030198 | extracellular matrix organization | 21/202 | 393/18862 | 0 | 0e+00 | 21 |
GO:0043062 | extracellular structure organization | 21/202 | 394/18862 | 0 | 0e+00 | 21 |
GO:0045229 | external encapsulating structure organization | 21/202 | 396/18862 | 0 | 0e+00 | 21 |
GO:0050766 | positive regulation of phagocytosis | 10/202 | 67/18862 | 0 | 0e+00 | 10 |
GO:0030155 | regulation of cell adhesion | 28/202 | 732/18862 | 0 | 0e+00 | 28 |
GO:0050764 | regulation of phagocytosis | 11/202 | 94/18862 | 0 | 0e+00 | 11 |
GO:0060627 | regulation of vesicle-mediated transport | 23/202 | 513/18862 | 0 | 0e+00 | 23 |
GO:0051050 | positive regulation of transport | 30/202 | 883/18862 | 0 | 0e+00 | 30 |
GO:0019221 | cytokine-mediated signaling pathway | 28/202 | 804/18862 | 0 | 0e+00 | 28 |
GO:0071219 | cellular response to molecule of bacterial origin | 14/202 | 209/18862 | 0 | 0e+00 | 14 |
GO:0002576 | platelet degranulation | 11/202 | 128/18862 | 0 | 0e+00 | 11 |
GO:0042110 | T cell activation | 20/202 | 474/18862 | 0 | 0e+00 | 20 |
GO:0071222 | cellular response to lipopolysaccharide | 13/202 | 197/18862 | 0 | 0e+00 | 13 |
GO:0071216 | cellular response to biotic stimulus | 14/202 | 233/18862 | 0 | 0e+00 | 14 |
GO:0045576 | mast cell activation | 8/202 | 60/18862 | 0 | 0e+00 | 8 |
GO:0043300 | regulation of leukocyte degranulation | 7/202 | 43/18862 | 0 | 0e+00 | 7 |
GO:0043303 | mast cell degranulation | 7/202 | 46/18862 | 0 | 1e-04 | 7 |
GO:0071396 | cellular response to lipid | 21/202 | 556/18862 | 0 | 1e-04 | 21 |
GO:0002279 | mast cell activation involved in immune response | 7/202 | 47/18862 | 0 | 1e-04 | 7 |
GO:0002448 | mast cell mediated immunity | 7/202 | 47/18862 | 0 | 1e-04 | 7 |
GO:0097529 | myeloid leukocyte migration | 13/202 | 218/18862 | 0 | 1e-04 | 13 |
GO:0003013 | circulatory system process | 22/202 | 610/18862 | 0 | 1e-04 | 22 |
GO:0045785 | positive regulation of cell adhesion | 18/202 | 425/18862 | 0 | 1e-04 | 18 |
GO:0030595 | leukocyte chemotaxis | 13/202 | 226/18862 | 0 | 1e-04 | 13 |
GO:0010035 | response to inorganic substance | 20/202 | 542/18862 | 0 | 1e-04 | 20 |
GO:0050900 | leukocyte migration | 19/202 | 509/18862 | 0 | 2e-04 | 19 |
GO:0060548 | negative regulation of cell death | 28/202 | 992/18862 | 0 | 2e-04 | 28 |
GO:0006959 | humoral immune response | 16/202 | 380/18862 | 0 | 3e-04 | 16 |
GO:0030162 | regulation of proteolysis | 23/202 | 733/18862 | 0 | 3e-04 | 23 |
GO:0008015 | blood circulation | 19/202 | 527/18862 | 0 | 3e-04 | 19 |
GO:0043069 | negative regulation of programmed cell death | 26/202 | 902/18862 | 0 | 3e-04 | 26 |
GO:0044089 | positive regulation of cellular component biogenesis | 19/202 | 528/18862 | 0 | 3e-04 | 19 |
GO:0030334 | regulation of cell migration | 27/202 | 962/18862 | 0 | 3e-04 | 27 |
GO:0014070 | response to organic cyclic compound | 26/202 | 907/18862 | 0 | 3e-04 | 26 |
GO:0000165 | MAPK cascade | 26/202 | 913/18862 | 0 | 4e-04 | 26 |
GO:0007568 | aging | 14/202 | 304/18862 | 0 | 4e-04 | 14 |
GO:0003073 | regulation of systemic arterial blood pressure | 8/202 | 90/18862 | 0 | 4e-04 | 8 |
GO:0060326 | cell chemotaxis | 14/202 | 306/18862 | 0 | 4e-04 | 14 |
GO:0006935 | chemotaxis | 21/202 | 643/18862 | 0 | 4e-04 | 21 |
GO:0046649 | lymphocyte activation | 23/202 | 752/18862 | 0 | 4e-04 | 23 |
GO:0042330 | taxis | 21/202 | 645/18862 | 0 | 4e-04 | 21 |
GO:1903409 | reactive oxygen species biosynthetic process | 9/202 | 123/18862 | 0 | 4e-04 | 9 |
GO:0009611 | response to wounding | 21/202 | 654/18862 | 0 | 4e-04 | 21 |
GO:0043408 | regulation of MAPK cascade | 22/202 | 708/18862 | 0 | 4e-04 | 22 |
GO:0042493 | response to drug | 15/202 | 359/18862 | 0 | 5e-04 | 15 |
GO:0019725 | cellular homeostasis | 26/202 | 937/18862 | 0 | 5e-04 | 26 |
GO:0051046 | regulation of secretion | 20/202 | 613/18862 | 0 | 6e-04 | 20 |
GO:0051345 | positive regulation of hydrolase activity | 23/202 | 776/18862 | 0 | 6e-04 | 23 |
GO:0002697 | regulation of immune effector process | 17/202 | 465/18862 | 0 | 6e-04 | 17 |
GO:0043304 | regulation of mast cell degranulation | 5/202 | 29/18862 | 0 | 7e-04 | 5 |
GO:1901652 | response to peptide | 18/202 | 521/18862 | 0 | 7e-04 | 18 |
GO:0032418 | lysosome localization | 7/202 | 74/18862 | 0 | 7e-04 | 7 |
GO:0002521 | leukocyte differentiation | 18/202 | 525/18862 | 0 | 8e-04 | 18 |
GO:0033006 | regulation of mast cell activation involved in immune response | 5/202 | 30/18862 | 0 | 8e-04 | 5 |
GO:0006909 | phagocytosis | 15/202 | 381/18862 | 0 | 8e-04 | 15 |
GO:0050865 | regulation of cell activation | 20/202 | 633/18862 | 0 | 8e-04 | 20 |
GO:0002703 | regulation of leukocyte mediated immunity | 11/202 | 209/18862 | 0 | 8e-04 | 11 |
GO:0040017 | positive regulation of locomotion | 19/202 | 586/18862 | 0 | 9e-04 | 19 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 6/202 | 52/18862 | 0 | 9e-04 | 6 |
GO:0071417 | cellular response to organonitrogen compound | 20/202 | 643/18862 | 0 | 9e-04 | 20 |
GO:1901699 | cellular response to nitrogen compound | 21/202 | 698/18862 | 0 | 9e-04 | 21 |
GO:0022407 | regulation of cell-cell adhesion | 16/202 | 437/18862 | 0 | 9e-04 | 16 |
ID | Description | GeneRatio | BgRatio | pvalue | p.adjust | Count |
---|---|---|---|---|---|---|
GO:1903047 | mitotic cell cycle process | 30/139 | 886/18862 | 0 | 0e+00 | 30 |
GO:0044772 | mitotic cell cycle phase transition | 22/139 | 595/18862 | 0 | 0e+00 | 22 |
GO:0044770 | cell cycle phase transition | 22/139 | 641/18862 | 0 | 0e+00 | 22 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 17/139 | 439/18862 | 0 | 0e+00 | 17 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 12/139 | 203/18862 | 0 | 0e+00 | 12 |
GO:0010564 | regulation of cell cycle process | 22/139 | 789/18862 | 0 | 0e+00 | 22 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 12/139 | 219/18862 | 0 | 0e+00 | 12 |
GO:1901987 | regulation of cell cycle phase transition | 17/139 | 478/18862 | 0 | 0e+00 | 17 |
GO:0016032 | viral process | 24/139 | 942/18862 | 0 | 0e+00 | 24 |
GO:0007346 | regulation of mitotic cell cycle | 19/139 | 605/18862 | 0 | 0e+00 | 19 |
GO:0006259 | DNA metabolic process | 24/139 | 954/18862 | 0 | 0e+00 | 24 |
GO:0044403 | biological process involved in symbiotic interaction | 24/139 | 1000/18862 | 0 | 1e-04 | 24 |
GO:0006974 | cellular response to DNA damage stimulus | 22/139 | 869/18862 | 0 | 1e-04 | 22 |
GO:0000086 | G2/M transition of mitotic cell cycle | 12/139 | 258/18862 | 0 | 1e-04 | 12 |
GO:0033673 | negative regulation of kinase activity | 12/139 | 267/18862 | 0 | 1e-04 | 12 |
GO:0044839 | cell cycle G2/M phase transition | 12/139 | 276/18862 | 0 | 2e-04 | 12 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 9/139 | 145/18862 | 0 | 2e-04 | 9 |
GO:0006469 | negative regulation of protein kinase activity | 11/139 | 243/18862 | 0 | 3e-04 | 11 |
GO:0051348 | negative regulation of transferase activity | 12/139 | 296/18862 | 0 | 3e-04 | 12 |
GO:0006281 | DNA repair | 16/139 | 569/18862 | 0 | 7e-04 | 16 |
GO:0050851 | antigen receptor-mediated signaling pathway | 12/139 | 323/18862 | 0 | 7e-04 | 12 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 15/139 | 515/18862 | 0 | 8e-04 | 15 |
GO:0002764 | immune response-regulating signaling pathway | 15/139 | 518/18862 | 0 | 8e-04 | 15 |
ID | Description | GeneRatio | BgRatio | pvalue | p.adjust | Count |
---|---|---|---|---|---|---|
GO:0002366 | leukocyte activation involved in immune response | 54/176 | 718/18862 | 0 | 0e+00 | 54 |
GO:0002263 | cell activation involved in immune response | 54/176 | 722/18862 | 0 | 0e+00 | 54 |
GO:0036230 | granulocyte activation | 47/176 | 506/18862 | 0 | 0e+00 | 47 |
GO:0002274 | myeloid leukocyte activation | 51/176 | 659/18862 | 0 | 0e+00 | 51 |
GO:0042119 | neutrophil activation | 46/176 | 500/18862 | 0 | 0e+00 | 46 |
GO:0043299 | leukocyte degranulation | 46/176 | 535/18862 | 0 | 0e+00 | 46 |
GO:0045055 | regulated exocytosis | 53/176 | 779/18862 | 0 | 0e+00 | 53 |
GO:0043312 | neutrophil degranulation | 44/176 | 485/18862 | 0 | 0e+00 | 44 |
GO:0002275 | myeloid cell activation involved in immune response | 46/176 | 548/18862 | 0 | 0e+00 | 46 |
GO:0002283 | neutrophil activation involved in immune response | 44/176 | 488/18862 | 0 | 0e+00 | 44 |
GO:0002444 | myeloid leukocyte mediated immunity | 46/176 | 550/18862 | 0 | 0e+00 | 46 |
GO:0002446 | neutrophil mediated immunity | 44/176 | 499/18862 | 0 | 0e+00 | 44 |
GO:0006887 | exocytosis | 55/176 | 891/18862 | 0 | 0e+00 | 55 |
GO:0002443 | leukocyte mediated immunity | 50/176 | 882/18862 | 0 | 0e+00 | 50 |
GO:0019221 | cytokine-mediated signaling pathway | 34/176 | 804/18862 | 0 | 0e+00 | 34 |
GO:0001816 | cytokine production | 30/176 | 823/18862 | 0 | 0e+00 | 30 |
GO:0002576 | platelet degranulation | 13/176 | 128/18862 | 0 | 0e+00 | 13 |
GO:0030155 | regulation of cell adhesion | 27/176 | 732/18862 | 0 | 0e+00 | 27 |
GO:0019725 | cellular homeostasis | 30/176 | 937/18862 | 0 | 0e+00 | 30 |
GO:0045785 | positive regulation of cell adhesion | 20/176 | 425/18862 | 0 | 0e+00 | 20 |
GO:0051050 | positive regulation of transport | 28/176 | 883/18862 | 0 | 0e+00 | 28 |
GO:0001817 | regulation of cytokine production | 26/176 | 781/18862 | 0 | 0e+00 | 26 |
GO:0062197 | cellular response to chemical stress | 17/176 | 347/18862 | 0 | 0e+00 | 17 |
GO:2001233 | regulation of apoptotic signaling pathway | 17/176 | 348/18862 | 0 | 0e+00 | 17 |
GO:0060548 | negative regulation of cell death | 29/176 | 992/18862 | 0 | 0e+00 | 29 |
GO:0009725 | response to hormone | 27/176 | 876/18862 | 0 | 0e+00 | 27 |
GO:0030003 | cellular cation homeostasis | 23/176 | 655/18862 | 0 | 0e+00 | 23 |
GO:0043066 | negative regulation of apoptotic process | 27/176 | 881/18862 | 0 | 0e+00 | 27 |
GO:0008284 | positive regulation of cell population proliferation | 28/176 | 941/18862 | 0 | 0e+00 | 28 |
GO:0007159 | leukocyte cell-cell adhesion | 17/176 | 366/18862 | 0 | 0e+00 | 17 |
GO:0006873 | cellular ion homeostasis | 23/176 | 668/18862 | 0 | 0e+00 | 23 |
GO:0032496 | response to lipopolysaccharide | 16/176 | 326/18862 | 0 | 0e+00 | 16 |
GO:0032870 | cellular response to hormone stimulus | 22/176 | 619/18862 | 0 | 0e+00 | 22 |
GO:0043069 | negative regulation of programmed cell death | 27/176 | 902/18862 | 0 | 0e+00 | 27 |
GO:0055080 | cation homeostasis | 24/176 | 730/18862 | 0 | 0e+00 | 24 |
GO:0050801 | ion homeostasis | 25/176 | 787/18862 | 0 | 0e+00 | 25 |
GO:0098771 | inorganic ion homeostasis | 24/176 | 740/18862 | 0 | 0e+00 | 24 |
GO:0002700 | regulation of production of molecular mediator of immune response | 11/176 | 146/18862 | 0 | 0e+00 | 11 |
GO:0055082 | cellular chemical homeostasis | 25/176 | 811/18862 | 0 | 0e+00 | 25 |
GO:0006935 | chemotaxis | 22/176 | 643/18862 | 0 | 0e+00 | 22 |
GO:0042330 | taxis | 22/176 | 645/18862 | 0 | 0e+00 | 22 |
GO:0002237 | response to molecule of bacterial origin | 16/176 | 346/18862 | 0 | 0e+00 | 16 |
GO:0098609 | cell-cell adhesion | 26/176 | 880/18862 | 0 | 0e+00 | 26 |
GO:0002285 | lymphocyte activation involved in immune response | 12/176 | 189/18862 | 0 | 0e+00 | 12 |
GO:0031589 | cell-substrate adhesion | 16/176 | 359/18862 | 0 | 0e+00 | 16 |
GO:1903039 | positive regulation of leukocyte cell-cell adhesion | 13/176 | 234/18862 | 0 | 0e+00 | 13 |
GO:0071222 | cellular response to lipopolysaccharide | 12/176 | 197/18862 | 0 | 0e+00 | 12 |
GO:0001818 | negative regulation of cytokine production | 16/176 | 367/18862 | 0 | 0e+00 | 16 |
GO:2000379 | positive regulation of reactive oxygen species metabolic process | 9/176 | 101/18862 | 0 | 0e+00 | 9 |
GO:0090322 | regulation of superoxide metabolic process | 6/176 | 32/18862 | 0 | 0e+00 | 6 |
GO:0033993 | response to lipid | 25/176 | 865/18862 | 0 | 0e+00 | 25 |
GO:0097190 | apoptotic signaling pathway | 20/176 | 580/18862 | 0 | 0e+00 | 20 |
GO:0032930 | positive regulation of superoxide anion generation | 5/176 | 18/18862 | 0 | 0e+00 | 5 |
GO:0052548 | regulation of endopeptidase activity | 17/176 | 426/18862 | 0 | 0e+00 | 17 |
GO:0071219 | cellular response to molecule of bacterial origin | 12/176 | 209/18862 | 0 | 0e+00 | 12 |
GO:0043086 | negative regulation of catalytic activity | 24/176 | 818/18862 | 0 | 0e+00 | 24 |
GO:0006914 | autophagy | 19/176 | 536/18862 | 0 | 0e+00 | 19 |
GO:0061919 | process utilizing autophagic mechanism | 19/176 | 536/18862 | 0 | 0e+00 | 19 |
GO:0034599 | cellular response to oxidative stress | 14/176 | 299/18862 | 0 | 1e-04 | 14 |
GO:0032928 | regulation of superoxide anion generation | 5/176 | 20/18862 | 0 | 1e-04 | 5 |
GO:0033572 | transferrin transport | 6/176 | 36/18862 | 0 | 1e-04 | 6 |
GO:0006954 | inflammatory response | 23/176 | 775/18862 | 0 | 1e-04 | 23 |
GO:0097191 | extrinsic apoptotic signaling pathway | 12/176 | 217/18862 | 0 | 1e-04 | 12 |
GO:0002286 | T cell activation involved in immune response | 9/176 | 111/18862 | 0 | 1e-04 | 9 |
GO:0009617 | response to bacterium | 22/176 | 724/18862 | 0 | 1e-04 | 22 |
GO:0045597 | positive regulation of cell differentiation | 24/176 | 845/18862 | 0 | 1e-04 | 24 |
GO:0014070 | response to organic cyclic compound | 25/176 | 907/18862 | 0 | 1e-04 | 25 |
GO:0033002 | muscle cell proliferation | 12/176 | 222/18862 | 0 | 1e-04 | 12 |
GO:0052547 | regulation of peptidase activity | 17/176 | 455/18862 | 0 | 1e-04 | 17 |
GO:2001234 | negative regulation of apoptotic signaling pathway | 12/176 | 224/18862 | 0 | 1e-04 | 12 |
GO:0050900 | leukocyte migration | 18/176 | 509/18862 | 0 | 1e-04 | 18 |
GO:2001236 | regulation of extrinsic apoptotic signaling pathway | 10/176 | 154/18862 | 0 | 1e-04 | 10 |
GO:0048534 | hematopoietic or lymphoid organ development | 25/176 | 932/18862 | 0 | 1e-04 | 25 |
GO:0050865 | regulation of cell activation | 20/176 | 633/18862 | 0 | 1e-04 | 20 |
GO:0071216 | cellular response to biotic stimulus | 12/176 | 233/18862 | 0 | 1e-04 | 12 |
GO:0022409 | positive regulation of cell-cell adhesion | 13/176 | 276/18862 | 0 | 1e-04 | 13 |
GO:0042110 | T cell activation | 17/176 | 474/18862 | 0 | 1e-04 | 17 |
GO:0045628 | regulation of T-helper 2 cell differentiation | 4/176 | 11/18862 | 0 | 1e-04 | 4 |
GO:0051272 | positive regulation of cellular component movement | 19/176 | 585/18862 | 0 | 1e-04 | 19 |
GO:0072593 | reactive oxygen species metabolic process | 13/176 | 281/18862 | 0 | 1e-04 | 13 |
GO:0001934 | positive regulation of protein phosphorylation | 23/176 | 824/18862 | 0 | 1e-04 | 23 |
GO:1903037 | regulation of leukocyte cell-cell adhesion | 14/176 | 330/18862 | 0 | 1e-04 | 14 |
GO:0055065 | metal ion homeostasis | 20/176 | 647/18862 | 0 | 1e-04 | 20 |
GO:0002637 | regulation of immunoglobulin production | 7/176 | 67/18862 | 0 | 1e-04 | 7 |
GO:0002440 | production of molecular mediator of immune response | 13/176 | 286/18862 | 0 | 1e-04 | 13 |
GO:0009611 | response to wounding | 20/176 | 654/18862 | 0 | 1e-04 | 20 |
GO:0010951 | negative regulation of endopeptidase activity | 12/176 | 245/18862 | 0 | 1e-04 | 12 |
GO:0030335 | positive regulation of cell migration | 18/176 | 549/18862 | 0 | 2e-04 | 18 |
GO:0043112 | receptor metabolic process | 10/176 | 168/18862 | 0 | 2e-04 | 10 |
GO:0007599 | hemostasis | 14/176 | 346/18862 | 0 | 2e-04 | 14 |
GO:0045861 | negative regulation of proteolysis | 14/176 | 346/18862 | 0 | 2e-04 | 14 |
GO:0050878 | regulation of body fluid levels | 17/176 | 503/18862 | 0 | 2e-04 | 17 |
GO:0002520 | immune system development | 25/176 | 989/18862 | 0 | 2e-04 | 25 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 8/176 | 103/18862 | 0 | 2e-04 | 8 |
GO:0010466 | negative regulation of peptidase activity | 12/176 | 257/18862 | 0 | 2e-04 | 12 |
GO:0051346 | negative regulation of hydrolase activity | 16/176 | 456/18862 | 0 | 2e-04 | 16 |
GO:0002699 | positive regulation of immune effector process | 11/176 | 219/18862 | 0 | 2e-04 | 11 |
GO:2000147 | positive regulation of cell motility | 18/176 | 573/18862 | 0 | 3e-04 | 18 |
GO:0046649 | lymphocyte activation | 21/176 | 752/18862 | 0 | 3e-04 | 21 |
GO:0006875 | cellular metal ion homeostasis | 18/176 | 575/18862 | 0 | 3e-04 | 18 |
GO:0050867 | positive regulation of cell activation | 15/176 | 412/18862 | 0 | 3e-04 | 15 |
GO:0002697 | regulation of immune effector process | 16/176 | 465/18862 | 0 | 3e-04 | 16 |
GO:0006826 | iron ion transport | 7/176 | 79/18862 | 0 | 3e-04 | 7 |
GO:0045064 | T-helper 2 cell differentiation | 4/176 | 15/18862 | 0 | 3e-04 | 4 |
GO:0031623 | receptor internalization | 8/176 | 111/18862 | 0 | 3e-04 | 8 |
GO:0030097 | hemopoiesis | 23/176 | 892/18862 | 0 | 3e-04 | 23 |
GO:0040017 | positive regulation of locomotion | 18/176 | 586/18862 | 0 | 3e-04 | 18 |
GO:0097530 | granulocyte migration | 9/176 | 148/18862 | 0 | 3e-04 | 9 |
GO:0022617 | extracellular matrix disassembly | 7/176 | 81/18862 | 0 | 3e-04 | 7 |
GO:0042060 | wound healing | 17/176 | 535/18862 | 0 | 4e-04 | 17 |
GO:0002694 | regulation of leukocyte activation | 18/176 | 594/18862 | 0 | 4e-04 | 18 |
GO:0071375 | cellular response to peptide hormone stimulus | 13/176 | 325/18862 | 0 | 4e-04 | 13 |
GO:0097067 | cellular response to thyroid hormone stimulus | 4/176 | 16/18862 | 0 | 4e-04 | 4 |
GO:0042327 | positive regulation of phosphorylation | 23/176 | 908/18862 | 0 | 4e-04 | 23 |
GO:0006898 | receptor-mediated endocytosis | 13/176 | 328/18862 | 0 | 4e-04 | 13 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 10/176 | 192/18862 | 0 | 4e-04 | 10 |
GO:0097193 | intrinsic apoptotic signaling pathway | 12/176 | 283/18862 | 0 | 4e-04 | 12 |
GO:0043434 | response to peptide hormone | 15/176 | 435/18862 | 0 | 4e-04 | 15 |
GO:0010562 | positive regulation of phosphorus metabolic process | 24/176 | 982/18862 | 0 | 4e-04 | 24 |
GO:0045937 | positive regulation of phosphate metabolic process | 24/176 | 982/18862 | 0 | 4e-04 | 24 |
GO:0046916 | cellular transition metal ion homeostasis | 8/176 | 118/18862 | 0 | 4e-04 | 8 |
GO:0001819 | positive regulation of cytokine production | 15/176 | 437/18862 | 0 | 4e-04 | 15 |
GO:0022407 | regulation of cell-cell adhesion | 15/176 | 437/18862 | 0 | 4e-04 | 15 |
GO:0045851 | pH reduction | 6/176 | 58/18862 | 0 | 5e-04 | 6 |
GO:0003013 | circulatory system process | 18/176 | 610/18862 | 0 | 5e-04 | 18 |
GO:0070663 | regulation of leukocyte proliferation | 11/176 | 241/18862 | 0 | 5e-04 | 11 |
GO:0042554 | superoxide anion generation | 5/176 | 35/18862 | 0 | 5e-04 | 5 |
GO:0030162 | regulation of proteolysis | 20/176 | 733/18862 | 0 | 5e-04 | 20 |
GO:1901653 | cellular response to peptide | 14/176 | 391/18862 | 0 | 5e-04 | 14 |
GO:0048660 | regulation of smooth muscle cell proliferation | 9/176 | 160/18862 | 0 | 5e-04 | 9 |
GO:2001242 | regulation of intrinsic apoptotic signaling pathway | 9/176 | 160/18862 | 0 | 5e-04 | 9 |
GO:0002523 | leukocyte migration involved in inflammatory response | 4/176 | 18/18862 | 0 | 5e-04 | 4 |
GO:1990266 | neutrophil migration | 8/176 | 123/18862 | 0 | 5e-04 | 8 |
GO:0007596 | blood coagulation | 13/176 | 342/18862 | 0 | 5e-04 | 13 |
GO:0070997 | neuron death | 13/176 | 342/18862 | 0 | 5e-04 | 13 |
GO:0071621 | granulocyte chemotaxis | 8/176 | 124/18862 | 0 | 6e-04 | 8 |
GO:0048659 | smooth muscle cell proliferation | 9/176 | 162/18862 | 0 | 6e-04 | 9 |
GO:0050817 | coagulation | 13/176 | 347/18862 | 0 | 6e-04 | 13 |
GO:0002696 | positive regulation of leukocyte activation | 14/176 | 401/18862 | 0 | 6e-04 | 14 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 4/176 | 19/18862 | 0 | 6e-04 | 4 |
GO:1905477 | positive regulation of protein localization to membrane | 8/176 | 127/18862 | 0 | 6e-04 | 8 |
GO:0010742 | macrophage derived foam cell differentiation | 5/176 | 38/18862 | 0 | 6e-04 | 5 |
GO:0090077 | foam cell differentiation | 5/176 | 38/18862 | 0 | 6e-04 | 5 |
GO:0097242 | amyloid-beta clearance | 5/176 | 38/18862 | 0 | 6e-04 | 5 |
GO:1901214 | regulation of neuron death | 12/176 | 302/18862 | 0 | 7e-04 | 12 |
GO:0002701 | negative regulation of production of molecular mediator of immune response | 5/176 | 39/18862 | 0 | 7e-04 | 5 |
GO:0030212 | hyaluronan metabolic process | 5/176 | 39/18862 | 0 | 7e-04 | 5 |
GO:0032602 | chemokine production | 7/176 | 95/18862 | 0 | 7e-04 | 7 |
GO:0050870 | positive regulation of T cell activation | 10/176 | 212/18862 | 0 | 7e-04 | 10 |
GO:1901652 | response to peptide | 16/176 | 521/18862 | 0 | 7e-04 | 16 |
GO:0070265 | necrotic cell death | 6/176 | 65/18862 | 0 | 7e-04 | 6 |
GO:0030334 | regulation of cell migration | 23/176 | 962/18862 | 0 | 7e-04 | 23 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 7/176 | 96/18862 | 0 | 7e-04 | 7 |
GO:0016236 | macroautophagy | 12/176 | 311/18862 | 0 | 8e-04 | 12 |
GO:0034394 | protein localization to cell surface | 6/176 | 67/18862 | 0 | 9e-04 | 6 |
GO:0070661 | leukocyte proliferation | 12/176 | 312/18862 | 0 | 9e-04 | 12 |
GO:0010810 | regulation of cell-substrate adhesion | 10/176 | 218/18862 | 0 | 9e-04 | 10 |
GO:0097529 | myeloid leukocyte migration | 10/176 | 218/18862 | 0 | 9e-04 | 10 |
GO:0040007 | growth | 22/176 | 908/18862 | 0 | 9e-04 | 22 |